microRNA information: hsa-miR-26a-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-26a-5p | miRbase |
Accession: | MIMAT0000082 | miRbase |
Precursor name: | hsa-mir-26a-1 | miRbase |
Precursor accession: | MI0000083 | miRbase |
Symbol: | MIR26A1 | HGNC |
RefSeq ID: | NR_029499 | GenBank |
Sequence: | UUCAAGUAAUCCAGGAUAGGCU |
Reported expression in cancers: hsa-miR-26a-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-26a-5p | bladder cancer | downregulation | "Recently emerging evidence suggested that miR-26a ......" | 23796420 | |
hsa-miR-26a-5p | bladder cancer | downregulation | "In the present study it was found that miR-26a was ......" | 24682444 | |
hsa-miR-26a-5p | bladder cancer | downregulation | "Previous studies have revealed that miR-26a-5p and ......" | 27310702 | |
hsa-miR-26a-5p | breast cancer | downregulation | "The role of miR-26a in carcinogenesis appears to b ......" | 20952513 | |
hsa-miR-26a-5p | breast cancer | downregulation | "Here we demonstrate that miR-26a is down-regulated ......" | 23750239 | |
hsa-miR-26a-5p | breast cancer | downregulation | "It has been reported that miR-26a plays an importa ......" | 25434799 | |
hsa-miR-26a-5p | breast cancer | downregulation | "Reverse transcription-polymerase chain reaction RT ......" | 25755724 | Reverse transcription PCR |
hsa-miR-26a-5p | esophageal cancer | upregulation | "Expressions of miR-26a and miR-2bb were analyzed i ......" | 27347306 | |
hsa-miR-26a-5p | gastric cancer | downregulation | "Until now the role of miR-26a in gastric cancer re ......" | 24015269 | |
hsa-miR-26a-5p | gastric cancer | downregulation | "In our previous study we demonstrated that four mi ......" | 27529338 | Reverse transcription PCR; qPCR |
hsa-miR-26a-5p | glioblastoma | upregulation | "Although miR-26a has been reported to be upregulat ......" | 24140063 | |
hsa-miR-26a-5p | kidney renal cell cancer | downregulation | "To date few reports have provided functional analy ......" | 26983694 | |
hsa-miR-26a-5p | liver cancer | downregulation | "We demonstrate that hepatocellular carcinoma HCC c ......" | 19524505 | |
hsa-miR-26a-5p | liver cancer | downregulation | "Chromatin immunoprecipitation microarray was perfo ......" | 21829663 | Microarray; qPCR |
hsa-miR-26a-5p | liver cancer | downregulation | "A recent study showed that miR-26a is downregulate ......" | 23011405 | |
hsa-miR-26a-5p | liver cancer | downregulation | "Down-regulation of microRNA-26a miR-26a is associa ......" | 23389848 | |
hsa-miR-26a-5p | liver cancer | downregulation | "We identified seven miRNAs that are also downregul ......" | 23719066 | |
hsa-miR-26a-5p | liver cancer | downregulation | "MicroRNA miR-26a can suppress tumor growth and met ......" | 24259426 | |
hsa-miR-26a-5p | liver cancer | downregulation | "miR-26 family members have been shown to be freque ......" | 24565101 | |
hsa-miR-26a-5p | lung cancer | downregulation | "Among them miR-26a has been identified as a tumor- ......" | 22469510 | |
hsa-miR-26a-5p | lung squamous cell cancer | deregulation | "Locked nucleic acids miRNA microarray expression p ......" | 20508945 | Microarray |
hsa-miR-26a-5p | melanoma | deregulation | "Comparative microarray analysis of microRNA expres ......" | 23111773 | Microarray; RNA-Seq; qPCR |
hsa-miR-26a-5p | ovarian cancer | downregulation | "The aim of this study was to find specific profile ......" | 23542579 | Microarray; qPCR |
hsa-miR-26a-5p | pancreatic cancer | upregulation | "The effects of miR-26a on cell growth apoptosis in ......" | 22245693 | |
hsa-miR-26a-5p | pancreatic cancer | downregulation | "miR-26a plays a critical role in tumorigenesis eit ......" | 24116110 | qPCR; Microarray; in situ hybridization |
hsa-miR-26a-5p | prostate cancer | downregulation | "Our past studies of microRNA miRNA expression sign ......" | 26063484 | |
hsa-miR-26a-5p | prostate cancer | downregulation | "The biological role of miR-26a involved in the car ......" | 27449037 | |
hsa-miR-26a-5p | sarcoma | downregulation | "microRNA-26a miR-26a has been identified as a tumo ......" | 24452597 |
Reported cancer pathway affected by hsa-miR-26a-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-26a-5p | acute myeloid leukemia | Apoptosis pathway | "We integrated miRNA and mRNA expression profiles o ......" | 21455993 | |
hsa-miR-26a-5p | acute myeloid leukemia | cell cycle pathway | "Critical Role of c Myc in Acute Myeloid Leukemia I ......" | 21901171 | |
hsa-miR-26a-5p | bladder cancer | cell cycle pathway | "miR 26a inhibits proliferation and motility in bla ......" | 23796420 | |
hsa-miR-26a-5p | bladder cancer | cell cycle pathway | "In the present study it was found that miR-26a was ......" | 24682444 | |
hsa-miR-26a-5p | breast cancer | Apoptosis pathway | "Pathologically decreased miR 26a antagonizes apopt ......" | 20952513 | |
hsa-miR-26a-5p | breast cancer | cell cycle pathway | "High miR 26a and low CDC2 levels associate with de ......" | 22094936 | |
hsa-miR-26a-5p | breast cancer | Apoptosis pathway | "Trastuzumab produces therapeutic actions by upregu ......" | 22384020 | |
hsa-miR-26a-5p | breast cancer | Apoptosis pathway | "MiR 26a inhibits proliferation and migration of br ......" | 23750239 | Colony formation |
hsa-miR-26a-5p | breast cancer | Apoptosis pathway | "The Antitumor Effect of Metformin Is Mediated by m ......" | 27517917 | MTT assay |
hsa-miR-26a-5p | colorectal cancer | Apoptosis pathway | "In the present study microarrays were used to anal ......" | 20831567 | |
hsa-miR-26a-5p | colorectal cancer | Apoptosis pathway | "In this study we performed a microarray analysis w ......" | 26494299 | RNA Immunoprecipitation; RNA immunoprecipitation; Western blot |
hsa-miR-26a-5p | esophageal cancer | cell cycle pathway | "Expressions of miR-26a and miR-2bb were analyzed i ......" | 27347306 | |
hsa-miR-26a-5p | gastric cancer | cell cycle pathway | "Similar to the restoring miR-26 expression SOCS2 d ......" | 25561270 | |
hsa-miR-26a-5p | gastric cancer | Apoptosis pathway | "MiR 26a enhances the sensitivity of gastric cancer ......" | 26458859 | Flow cytometry; Luciferase |
hsa-miR-26a-5p | gastric cancer | Apoptosis pathway | "In our previous study we demonstrated that four mi ......" | 27529338 | Colony formation |
hsa-miR-26a-5p | liver cancer | Apoptosis pathway | "Down-regulation of microRNA-26a miR-26a is associa ......" | 23389848 | |
hsa-miR-26a-5p | liver cancer | Epithelial mesenchymal transition pathway | "Our previous study reported that microRNA-26a miR- ......" | 26733151 | Western blot; Luciferase |
hsa-miR-26a-5p | liver cancer | Apoptosis pathway | "miR-26b-5p is one member of the mature miR-26 fami ......" | 26891666 | |
hsa-miR-26a-5p | lung cancer | Apoptosis pathway | "Among them miR-26a has been identified as a tumor- ......" | 22469510 | |
hsa-miR-26a-5p | lung cancer | PI3K/Akt signaling pathway | "The present study was undertaken to determine the ......" | 24788552 | |
hsa-miR-26a-5p | lung squamous cell cancer | cell cycle pathway | "MicroRNAs have recently emerged as key regulators ......" | 26492332 | Colony formation; Luciferase; Western blot |
hsa-miR-26a-5p | lymphoma | cell cycle pathway; Apoptosis pathway | "MicroRNA profiles were correlated with correspondi ......" | 21960592 | |
hsa-miR-26a-5p | melanoma | Apoptosis pathway | "We identified miR-26a through microarray and quant ......" | 23190898 | Luciferase |
hsa-miR-26a-5p | ovarian cancer | Apoptosis pathway | "miR 26a inhibits the proliferation of ovarian canc ......" | 27158389 | Flow cytometry; Colony formation; Luciferase |
hsa-miR-26a-5p | pancreatic cancer | Apoptosis pathway | "MicroRNAs real-time PCR Array was applied to inves ......" | 22245693 | Cell migration assay; Western blot; Luciferase |
hsa-miR-26a-5p | pancreatic cancer | cell cycle pathway | "The loss of miR 26a mediated post transcriptional ......" | 24116110 | Flow cytometry; Western blot |
hsa-miR-26a-5p | pancreatic cancer | cell cycle pathway | "MicroRNA miR-26a has been identified as a tumor su ......" | 26189069 | Western blot; Colony formation |
hsa-miR-26a-5p | prostate cancer | Epithelial mesenchymal transition pathway | "MiR 26a inhibits prostate cancer progression by re ......" | 24972966 | Western blot; Luciferase |
hsa-miR-26a-5p | prostate cancer | cell cycle pathway | "MiR 26a and miR 138 block the G1/S transition by t ......" | 27562865 | |
hsa-miR-26a-5p | sarcoma | cell cycle pathway | "To determine the role of miR-26 we reinstated its ......" | 25672572 | |
hsa-miR-26a-5p | sarcoma | Notch signaling pathway | "MiR 26a inhibits stem cell like phenotype and tumo ......" | 27270422 | |
hsa-miR-26a-5p | thyroid cancer | cell cycle pathway | "miR 26a and its target CKS2 modulate cell growth a ......" | 23861775 | Colony formation; Western blot; Luciferase |
Reported cancer prognosis affected by hsa-miR-26a-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-26a-5p | acute myeloid leukemia | differentiation; progression | "Critical Role of c Myc in Acute Myeloid Leukemia I ......" | 21901171 | |
hsa-miR-26a-5p | acute myeloid leukemia | differentiation | "In a previous study we showed that miR-26a was ind ......" | 23096114 | |
hsa-miR-26a-5p | bladder cancer | motility | "miR 26a inhibits proliferation and motility in bla ......" | 23796420 | |
hsa-miR-26a-5p | bladder cancer | worse prognosis | "In the present study it was found that miR-26a was ......" | 24682444 | |
hsa-miR-26a-5p | bladder cancer | progression; worse prognosis; staging; malignant trasformation | "Prognostic value of miR 26a and HMGA1 in urothelia ......" | 25455159 | |
hsa-miR-26a-5p | breast cancer | tumorigenesis | "Pathologically decreased miR 26a antagonizes apopt ......" | 20952513 | |
hsa-miR-26a-5p | breast cancer | tumorigenesis | "MiR 26a inhibits proliferation and migration of br ......" | 23750239 | Colony formation |
hsa-miR-26a-5p | breast cancer | metastasis; poor survival | "miR 26a suppresses tumour proliferation and metast ......" | 25434799 | |
hsa-miR-26a-5p | breast cancer | cell migration; motility; tumorigenesis | "To investigate the crucial role of miR-26a in brea ......" | 25755724 | Western blot; Luciferase; MTT assay |
hsa-miR-26a-5p | breast cancer | drug resistance | "The few available studies investigating microRNA i ......" | 26473850 | |
hsa-miR-26a-5p | breast cancer | poor survival; cell migration | "The Antitumor Effect of Metformin Is Mediated by m ......" | 27517917 | MTT assay |
hsa-miR-26a-5p | colorectal cancer | tumorigenesis; worse prognosis | "The miRs analyzed were as follows: miR-16 miR-21 m ......" | 25081869 | |
hsa-miR-26a-5p | colorectal cancer | progression | "Downloading from GEO Gene Expression Omnibus datab ......" | 25755742 | |
hsa-miR-26a-5p | gastric cancer | metastasis; staging; poor survival; progression | "miR 26a suppresses tumor growth and metastasis by ......" | 24015269 | Western blot; Luciferase |
hsa-miR-26a-5p | gastric cancer | progression | "Similar to the restoring miR-26 expression SOCS2 d ......" | 25561270 | |
hsa-miR-26a-5p | gastric cancer | staging | "Differentially expressed miRNAs were filtered with ......" | 27010210 | |
hsa-miR-26a-5p | kidney renal cell cancer | metastasis; cell migration | "To date few reports have provided functional analy ......" | 26983694 | Luciferase |
hsa-miR-26a-5p | liver cancer | poor survival; drug resistance | "In patients with hepatocellular carcinoma the expr ......" | 19812400 | |
hsa-miR-26a-5p | liver cancer | poor survival | "IL 6 upregulation contributes to the reduction of ......" | 23011405 | |
hsa-miR-26a-5p | liver cancer | worse prognosis; metastasis; recurrence; poor survival | "Down-regulation of microRNA-26a miR-26a is associa ......" | 23389848 | |
hsa-miR-26a-5p | liver cancer | poor survival; drug resistance | "Development of a miR 26 companion diagnostic test ......" | 23569435 | |
hsa-miR-26a-5p | liver cancer | progression | "In 2009 miR-26a delivery was shown to prevent HCC ......" | 23983424 | |
hsa-miR-26a-5p | liver cancer | metastasis; worse prognosis; poor survival; recurrence | "MicroRNA miR-26a can suppress tumor growth and met ......" | 24259426 | |
hsa-miR-26a-5p | liver cancer | poor survival | "miR-26 family members have been shown to be freque ......" | 24565101 | |
hsa-miR-26a-5p | liver cancer | cell migration | "The aim of this study was to find whether miR-26a ......" | 26021873 | Cell migration assay |
hsa-miR-26a-5p | liver cancer | progression; metastasis; motility | "Our previous study reported that microRNA-26a miR- ......" | 26733151 | Western blot; Luciferase |
hsa-miR-26a-5p | lung cancer | metastasis | "Among them miR-26a has been identified as a tumor- ......" | 22469510 | |
hsa-miR-26a-5p | lung cancer | metastasis; tumorigenesis; cell migration | "MiR 26a enhances metastasis potential of lung canc ......" | 22885155 | |
hsa-miR-26a-5p | lung cancer | tumorigenesis | "Other significantly differentiated miR families in ......" | 23035181 | |
hsa-miR-26a-5p | lung squamous cell cancer | drug resistance | "MicroRNAs have recently emerged as key regulators ......" | 26492332 | Colony formation; Luciferase; Western blot |
hsa-miR-26a-5p | lung squamous cell cancer | drug resistance | "miR 26a desensitizes non small cell lung cancer ce ......" | 27285768 | |
hsa-miR-26a-5p | lung squamous cell cancer | tumorigenesis | "Expression analysis of three miRNAs miR 26a miR 29 ......" | 27447710 | |
hsa-miR-26a-5p | lung squamous cell cancer | tumorigenesis | "KH type splicing regulatory protein KHSRP contribu ......" | 27644194 | |
hsa-miR-26a-5p | lymphoma | differentiation | "MicroRNA profiles were correlated with correspondi ......" | 21960592 | |
hsa-miR-26a-5p | lymphoma | staging | "Real time fluorescent quantitative PCR was used to ......" | 26314438 | |
hsa-miR-26a-5p | melanoma | metastasis; malignant trasformation | "Comparative microarray analysis of microRNA expres ......" | 23111773 | |
hsa-miR-26a-5p | ovarian cancer | tumorigenesis | "MiR 26a promotes ovarian cancer proliferation and ......" | 24466274 | |
hsa-miR-26a-5p | ovarian cancer | staging; differentiation | "miR 26a inhibits the proliferation of ovarian canc ......" | 27158389 | Flow cytometry; Colony formation; Luciferase |
hsa-miR-26a-5p | ovarian cancer | worse prognosis; drug resistance | "MicroRNAs such as miR-26a and miR-132 have been in ......" | 27673409 | |
hsa-miR-26a-5p | pancreatic cancer | poor survival; tumorigenesis | "The loss of miR 26a mediated post transcriptional ......" | 24116110 | Flow cytometry; Western blot |
hsa-miR-26a-5p | pancreatic cancer | cell migration | "MicroRNA miR-26a has been identified as a tumor su ......" | 26189069 | Western blot; Colony formation |
hsa-miR-26a-5p | prostate cancer | staging; malignant trasformation; progression | "The miR-26a expression profile was investigated us ......" | 20521394 | |
hsa-miR-26a-5p | prostate cancer | progression; metastasis | "MiR 26a inhibits prostate cancer progression by re ......" | 24972966 | Western blot; Luciferase |
hsa-miR-26a-5p | prostate cancer | tumorigenesis; metastasis; worse prognosis; motility | "Loss of miR 26a 5p promotes proliferation migratio ......" | 27449037 | Western blot; Luciferase |
hsa-miR-26a-5p | sarcoma | worse prognosis; staging; metastasis; poor survival; cell migration | "microRNA-26a miR-26a has been identified as a tumo ......" | 24452597 | |
hsa-miR-26a-5p | sarcoma | progression | "To determine the role of miR-26 we reinstated its ......" | 25672572 | |
hsa-miR-26a-5p | sarcoma | staging; metastasis; poor survival; progression | "However the expression of miR-26a and miR-27a in o ......" | 26377680 | |
hsa-miR-26a-5p | sarcoma | metastasis; poor survival | "MiR 26a inhibits stem cell like phenotype and tumo ......" | 27270422 | |
hsa-miR-26a-5p | thyroid cancer | tumorigenesis | "miR 26a and its target CKS2 modulate cell growth a ......" | 23861775 | Colony formation; Western blot; Luciferase |
Reported gene related to hsa-miR-26a-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-26a-5p | acute myeloid leukemia | EZH2 | "Previously EZH2 was shown to be regulated by miR-2 ......" | 21901171 |
hsa-miR-26a-5p | breast cancer | EZH2 | "Pathologically decreased miR 26a antagonizes apopt ......" | 20952513 |
hsa-miR-26a-5p | breast cancer | EZH2 | "MiR-26a has been reported as a tumor suppressor mi ......" | 23750239 |
hsa-miR-26a-5p | breast cancer | EZH2 | "miR-26a inhibition partly prevents the metformin v ......" | 27517917 |
hsa-miR-26a-5p | breast cancer | EZH2 | "High miR 26a and low CDC2 levels associate with de ......" | 22094936 |
hsa-miR-26a-5p | colorectal cancer | EZH2 | "Significant inverse correlation between EZH2 and h ......" | 25611389 |
hsa-miR-26a-5p | liver cancer | EZH2 | "Through down-regulation of EZH2 expression and up- ......" | 26733151 |
hsa-miR-26a-5p | liver cancer | EZH2 | "miR 26a promoted by interferon alpha inhibits hepa ......" | 25494962 |
hsa-miR-26a-5p | pancreatic cancer | EZH2 | "We also found that reexpression of miR-26a by tran ......" | 22086681 |
hsa-miR-26a-5p | prostate cancer | EZH2 | "In the present study the influence of miR-26a and ......" | 27562865 |
hsa-miR-26a-5p | prostate cancer | EZH2 | "We propose the hypermethylation of miR-26a as an a ......" | 22930729 |
hsa-miR-26a-5p | sarcoma | EZH2 | "Moreover EZH2 was upregulated and inversely correl ......" | 24452597 |
hsa-miR-26a-5p | bladder cancer | HMGA1 | "Prognostic value of miR 26a and HMGA1 in urothelia ......" | 25455159 |
hsa-miR-26a-5p | bladder cancer | HMGA1 | "miR 26a inhibits proliferation and motility in bla ......" | 23796420 |
hsa-miR-26a-5p | breast cancer | HMGA1 | "To investigate the crucial role of miR-26a in brea ......" | 25755724 |
hsa-miR-26a-5p | pancreatic cancer | HMGA1 | "HMGA1 was proved to be a target of miR-26a by Luci ......" | 22245693 |
hsa-miR-26a-5p | liver cancer | IL6 | "Interleukin-6 IL-6 was identified as a target of m ......" | 23389848 |
hsa-miR-26a-5p | liver cancer | IL6 | "Moreover tumors with reduced miR-26 expression had ......" | 19812400 |
hsa-miR-26a-5p | liver cancer | IL6 | "IL 6 upregulation contributes to the reduction of ......" | 23011405 |
hsa-miR-26a-5p | breast cancer | MTDH | "Pathologically decreased miR 26a antagonizes apopt ......" | 20952513 |
hsa-miR-26a-5p | breast cancer | MTDH | "MiR-26a has been reported as a tumor suppressor mi ......" | 23750239 |
hsa-miR-26a-5p | breast cancer | MTDH | "miR 26a suppresses tumour proliferation and metast ......" | 25434799 |
hsa-miR-26a-5p | breast cancer | PTEN | "miR-26a inhibition partly prevents the metformin v ......" | 27517917 |
hsa-miR-26a-5p | glioblastoma | PTEN | "We have shown that ectopic expression of miR-26a i ......" | 24140063 |
hsa-miR-26a-5p | lung cancer | PTEN | "MiR 26a enhances metastasis potential of lung canc ......" | 22885155 |
hsa-miR-26a-5p | acute myeloid leukemia | CCNE2 | "We also show that enforced expression of miR-26a i ......" | 21901171 |
hsa-miR-26a-5p | pancreatic cancer | CCNE2 | "The loss of miR 26a mediated post transcriptional ......" | 24116110 |
hsa-miR-26a-5p | lung cancer | CDC6 | "Here it is demonstrated that miR26a and miR26b inh ......" | 25100863 |
hsa-miR-26a-5p | ovarian cancer | CDC6 | "miR 26a inhibits the proliferation of ovarian canc ......" | 27158389 |
hsa-miR-26a-5p | acute myeloid leukemia | PCNA | "We also show that enforced expression of miR-26a i ......" | 21901171 |
hsa-miR-26a-5p | pancreatic cancer | PCNA | "The loss of miR 26a mediated post transcriptional ......" | 24116110 |
hsa-miR-26a-5p | bladder cancer | PLOD2 | "The gene encoding procollagen-lysine 2-oxoglutarat ......" | 27310702 |
hsa-miR-26a-5p | kidney renal cell cancer | PLOD2 | "Thus our data showed that two genes promoting meta ......" | 26983694 |
hsa-miR-26a-5p | liver cancer | TTR | "In multivariate analysis miR-26a or in combination ......" | 24259426 |
hsa-miR-26a-5p | liver cancer | TTR | "Patients with high miR-26a or low IL-6 in HCC tiss ......" | 23389848 |
hsa-miR-26a-5p | liver cancer | VEGFA | "Through gain- and loss-of-function studies miR-26a ......" | 24259426 |
hsa-miR-26a-5p | liver cancer | VEGFA | "The aims of this study were to investigate whether ......" | 24194905 |
hsa-miR-26a-5p | lung cancer | AKT1 | "Expression of phosphoinositide 3 kinase PI3K and p ......" | 24788552 |
hsa-miR-26a-5p | sarcoma | ALDH3A1 | "Here we demonstrated that miR-26a is downregulated ......" | 27270422 |
hsa-miR-26a-5p | prostate cancer | AMACR | "Furthermore over-expression of miR-26a reduced the ......" | 24517338 |
hsa-miR-26a-5p | breast cancer | ANXA5 | "An Annexin-V assay revealed that miR-26a but not m ......" | 22384020 |
hsa-miR-26a-5p | glioblastoma | ATM | "MiR 26a enhances the radiosensitivity of glioblast ......" | 24211747 |
hsa-miR-26a-5p | melanoma | BAG4 | "The luciferase reporter assays further demonstrate ......" | 23190898 |
hsa-miR-26a-5p | lung squamous cell cancer | BCL2 | "MiR-26a significantly decreased the expression of ......" | 26492332 |
hsa-miR-26a-5p | thyroid cancer | BCL2L1 | "CyclinB1 cyclinA bcl-xl and AKt are indirectly reg ......" | 23861775 |
hsa-miR-26a-5p | colorectal cancer | CASP3 | "The expression of cleaved caspase-3 was induced in ......" | 26494299 |
hsa-miR-26a-5p | breast cancer | CCNE1 | "Cell cycle regulation and CCNE1 and CDC2 were the ......" | 22094936 |
hsa-miR-26a-5p | melanoma | CDC37 | "In surveying targets of miR-26a we found that prot ......" | 23190898 |
hsa-miR-26a-5p | liver cancer | CDH1 | "Through down-regulation of EZH2 expression and up- ......" | 26733151 |
hsa-miR-26a-5p | lymphoma | CDK6 | "Maxvision immunohistochemistry technique was used ......" | 26314438 |
hsa-miR-26a-5p | thyroid cancer | CKS2 | "miR 26a and its target CKS2 modulate cell growth a ......" | 23861775 |
hsa-miR-26a-5p | liver cancer | CSF1 | "The aim of this study was to find whether miR-26a ......" | 26021873 |
hsa-miR-26a-5p | lung squamous cell cancer | E2F1 | "MiR-26a significantly decreased the expression of ......" | 26492332 |
hsa-miR-26a-5p | gastric cancer | E2F2 | "MiR 26a enhances the sensitivity of gastric cancer ......" | 26458859 |
hsa-miR-26a-5p | acute myeloid leukemia | E2F7 | "Here we identify E2F7 as a novel target of miR-26a ......" | 23096114 |
hsa-miR-26a-5p | pancreatic cancer | EPCAM | "We also found that reexpression of miR-26a by tran ......" | 22086681 |
hsa-miR-26a-5p | prostate cancer | ERG | "We propose the hypermethylation of miR-26a as an a ......" | 22930729 |
hsa-miR-26a-5p | gastric cancer | FGF9 | "miR 26a suppresses tumor growth and metastasis by ......" | 24015269 |
hsa-miR-26a-5p | liver cancer | FUT8 | "Furthermore using microRNA array we identified FUT ......" | 27533464 |
hsa-miR-26a-5p | liver cancer | HGF | "Hepatocyte growth factor HGF was identified as a t ......" | 24259426 |
hsa-miR-26a-5p | bladder cancer | HMGA2 | "Furthermore we demonstrated that high mobility gro ......" | 24682444 |
hsa-miR-26a-5p | thyroid cancer | HSF2 | "E2F HSF2 and miR 26 in thyroid carcinoma: bioinfor ......" | 26985959 |
hsa-miR-26a-5p | liver cancer | ITGA5 | "Furthermore we provide experimental evidence to co ......" | 25537511 |
hsa-miR-26a-5p | lung squamous cell cancer | KHSRP | "KH type splicing regulatory protein KHSRP contribu ......" | 27644194 |
hsa-miR-26a-5p | prostate cancer | LARP1 | "Gene expression data and in silico analysis showe ......" | 26063484 |
hsa-miR-26a-5p | kidney renal cell cancer | LOXL2 | "Thus our data showed that two genes promoting meta ......" | 26983694 |
hsa-miR-26a-5p | breast cancer | MCL1 | "MiR 26a inhibits proliferation and migration of br ......" | 23750239 |
hsa-miR-26a-5p | lung squamous cell cancer | MMP2 | "Additionally statistically significant negative co ......" | 27447710 |
hsa-miR-26a-5p | acute myeloid leukemia | MYC | "Our results identify new molecular targets of c-My ......" | 21901171 |
hsa-miR-26a-5p | lymphoma | NEK6 | "gga miR 26a targets NEK6 and suppresses Marek's di ......" | 24795301 |
hsa-miR-26a-5p | lymphoma | NFKB1 | "Functional validation in MCL cell lines demonstrat ......" | 20485376 |
hsa-miR-26a-5p | gastric cancer | NRAS | "MiR 26a enhances the sensitivity of gastric cancer ......" | 26458859 |
hsa-miR-26a-5p | colorectal cancer | PDHX | "The efficacy of miR-26a binding the 3'-untranslate ......" | 24935220 |
hsa-miR-26a-5p | breast cancer | PGR | "In addition a transcriptome analysis revealed that ......" | 19826037 |
hsa-miR-26a-5p | acute myeloid leukemia | PRDX3 | "Notably we demonstrated that peroxiredoxin III Prx ......" | 24828865 |
hsa-miR-26a-5p | lymphoma | PTLS | "Significant down-regulation of hsa-miR-26a was obs ......" | 24327568 |
hsa-miR-26a-5p | lung squamous cell cancer | PTPN13 | "miR 26a desensitizes non small cell lung cancer ce ......" | 27285768 |
hsa-miR-26a-5p | colorectal cancer | REG1A | "The efficacy of miR-26a binding the 3'-untranslate ......" | 24935220 |
hsa-miR-26a-5p | prostate cancer | SERBP1 | "Loss of miR 26a 5p promotes proliferation migratio ......" | 27449037 |
hsa-miR-26a-5p | prostate cancer | SERPINE1 | "Using bioinformatics analysis we found that serpin ......" | 27449037 |
hsa-miR-26a-5p | melanoma | SMAD1 | "In surveying targets of miR-26a we found that prot ......" | 23190898 |
hsa-miR-26a-5p | gastric cancer | SOCS2 | "Similar to the restoring miR-26 expression SOCS2 d ......" | 25561270 |
hsa-miR-26a-5p | liver cancer | TERT | "The purpose of this study was to investigate wheth ......" | 21610700 |
hsa-miR-26a-5p | lung cancer | TLR9 | "The present study was undertaken to determine the ......" | 24788552 |
hsa-miR-26a-5p | pancreatic cancer | TP53 | "We therefore examined whether miR-26a treatment ca ......" | 26189069 |
hsa-miR-26a-5p | lung squamous cell cancer | TXK | "miR 26a desensitizes non small cell lung cancer ce ......" | 27285768 |
hsa-miR-26a-5p | prostate cancer | WNT5A | "MiR 26a inhibits prostate cancer progression by re ......" | 24972966 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-26a-5p | CCDC43 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.076; TCGA BRCA -0.156; TCGA CESC -0.087; TCGA ESCA -0.148; TCGA HNSC -0.093; TCGA KIRC -0.093; TCGA KIRP -0.281; TCGA LIHC -0.133; TCGA LUAD -0.134; TCGA LUSC -0.295; TCGA OV -0.11; TCGA PRAD -0.163; TCGA THCA -0.093; TCGA UCEC -0.171 |
hsa-miR-26a-5p | FASN | 12 cancers: BLCA; BRCA; CESC; COAD; LGG; LIHC; LUAD; OV; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.179; TCGA BRCA -0.28; TCGA CESC -0.368; TCGA COAD -0.257; TCGA LGG -0.176; TCGA LIHC -0.341; TCGA LUAD -0.272; TCGA OV -0.225; TCGA PRAD -0.953; TCGA THCA -0.123; TCGA STAD -0.192; TCGA UCEC -0.455 |
hsa-miR-26a-5p | OLA1 | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.148; TCGA BRCA -0.134; TCGA ESCA -0.17; TCGA HNSC -0.151; TCGA KIRC -0.176; TCGA LIHC -0.209; TCGA LUAD -0.141; TCGA LUSC -0.521; TCGA OV -0.193; TCGA PAAD -0.142; TCGA PRAD -0.305; TCGA THCA -0.083; TCGA STAD -0.115; TCGA UCEC -0.172 |
hsa-miR-26a-5p | SERBP1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.075; TCGA BRCA -0.102; TCGA COAD -0.127; TCGA ESCA -0.161; TCGA HNSC -0.102; TCGA KIRC -0.086; TCGA LUAD -0.116; TCGA LUSC -0.236; TCGA PAAD -0.101; TCGA PRAD -0.112; TCGA SARC -0.092; TCGA STAD -0.178; TCGA UCEC -0.145 |
hsa-miR-26a-5p | TCP1 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.096; TCGA BRCA -0.238; TCGA CESC -0.121; TCGA ESCA -0.209; TCGA HNSC -0.136; TCGA LGG -0.054; TCGA LIHC -0.119; TCGA LUAD -0.143; TCGA LUSC -0.391; TCGA PRAD -0.465; TCGA SARC -0.095; TCGA STAD -0.288; TCGA UCEC -0.105 |
hsa-miR-26a-5p | TRAP1 | 12 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.118; TCGA BRCA -0.145; TCGA HNSC -0.066; TCGA KIRP -0.332; TCGA LGG -0.139; TCGA LIHC -0.109; TCGA LUAD -0.172; TCGA LUSC -0.415; TCGA PRAD -0.324; TCGA SARC -0.116; TCGA THCA -0.163; TCGA UCEC -0.173 |
hsa-miR-26a-5p | TUBG1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.139; TCGA BRCA -0.216; TCGA CESC -0.132; TCGA COAD -0.151; TCGA ESCA -0.247; TCGA HNSC -0.2; TCGA KIRP -0.233; TCGA LIHC -0.398; TCGA LUAD -0.394; TCGA LUSC -0.557; TCGA OV -0.248; TCGA PAAD -0.171; TCGA PRAD -0.355; TCGA SARC -0.189; TCGA THCA -0.302; TCGA UCEC -0.338 |
hsa-miR-26a-5p | YWHAE | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.174; TCGA BRCA -0.139; TCGA COAD -0.154; TCGA ESCA -0.158; TCGA HNSC -0.135; TCGA KIRP -0.207; TCGA LUSC -0.179; TCGA OV -0.156; TCGA PRAD -0.253; TCGA THCA -0.098; TCGA UCEC -0.126 |
hsa-miR-26a-5p | VLDLR | 9 cancers: BLCA; COAD; KIRC; KIRP; LIHC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.659; TCGA COAD -0.579; TCGA KIRC -0.335; TCGA KIRP -0.219; TCGA LIHC -0.513; TCGA OV -0.186; TCGA PRAD -0.247; TCGA SARC -0.287; TCGA UCEC -0.246 |
hsa-miR-26a-5p | UBE2G1 | 13 cancers: BLCA; BRCA; CESC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.087; TCGA BRCA -0.13; TCGA CESC -0.139; TCGA KIRP -0.116; TCGA LGG -0.054; TCGA LUAD -0.058; TCGA LUSC -0.231; TCGA OV -0.091; TCGA PRAD -0.211; TCGA SARC -0.079; TCGA THCA -0.07; TCGA STAD -0.181; TCGA UCEC -0.128 |
hsa-miR-26a-5p | EIF4G2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.092; TCGA BRCA -0.194; TCGA CESC -0.121; TCGA COAD -0.096; TCGA ESCA -0.128; TCGA KIRC -0.099; TCGA LUSC -0.104; TCGA PAAD -0.097; TCGA SARC -0.148; TCGA STAD -0.165; TCGA UCEC -0.133 |
hsa-miR-26a-5p | MTX2 | 10 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.119; TCGA BRCA -0.148; TCGA HNSC -0.228; TCGA LIHC -0.082; TCGA LUAD -0.105; TCGA LUSC -0.474; TCGA PRAD -0.5; TCGA SARC -0.191; TCGA THCA -0.161; TCGA UCEC -0.173 |
hsa-miR-26a-5p | PLOD2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.238; TCGA BRCA -0.29; TCGA CESC -0.433; TCGA COAD -0.372; TCGA ESCA -0.283; TCGA HNSC -0.146; TCGA KIRC -0.586; TCGA KIRP -0.308; TCGA LUAD -0.468; TCGA LUSC -0.662; TCGA OV -0.187; TCGA PAAD -0.452; TCGA SARC -0.286; TCGA THCA -0.213; TCGA STAD -0.245 |
hsa-miR-26a-5p | UBR3 | 9 cancers: BLCA; BRCA; CESC; ESCA; LGG; LUSC; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.161; TCGA BRCA -0.096; TCGA CESC -0.113; TCGA ESCA -0.129; TCGA LGG -0.074; TCGA LUSC -0.192; TCGA SARC -0.182; TCGA STAD -0.393; TCGA UCEC -0.15 |
hsa-miR-26a-5p | PEX13 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.124; TCGA BRCA -0.239; TCGA ESCA -0.185; TCGA HNSC -0.118; TCGA LUSC -0.282; TCGA OV -0.073; TCGA SARC -0.081; TCGA STAD -0.258; TCGA UCEC -0.165 |
hsa-miR-26a-5p | MAEA | 10 cancers: BLCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.083; TCGA HNSC -0.106; TCGA KIRP -0.083; TCGA LIHC -0.069; TCGA LUAD -0.119; TCGA LUSC -0.167; TCGA OV -0.122; TCGA PRAD -0.26; TCGA THCA -0.154; TCGA UCEC -0.076 |
hsa-miR-26a-5p | BFAR | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; UCEC | MirTarget | TCGA BLCA -0.095; TCGA BRCA -0.116; TCGA HNSC -0.079; TCGA KIRC -0.184; TCGA KIRP -0.251; TCGA LGG -0.062; TCGA LIHC -0.09; TCGA PAAD -0.228; TCGA UCEC -0.074 |
hsa-miR-26a-5p | CAMSAP1 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LUSC; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.116; TCGA BRCA -0.143; TCGA COAD -0.138; TCGA ESCA -0.329; TCGA KIRP -0.265; TCGA LGG -0.099; TCGA LUSC -0.277; TCGA SARC -0.15; TCGA STAD -0.38; TCGA UCEC -0.127 |
hsa-miR-26a-5p | CDK2AP1 | 10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; miRNATAP | TCGA BLCA -0.117; TCGA BRCA -0.138; TCGA HNSC -0.086; TCGA LGG -0.101; TCGA LIHC -0.123; TCGA LUAD -0.115; TCGA LUSC -0.358; TCGA PAAD -0.224; TCGA PRAD -0.281; TCGA THCA -0.213 |
hsa-miR-26a-5p | MTFMT | 9 cancers: BLCA; COAD; ESCA; HNSC; LUSC; OV; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.13; TCGA COAD -0.169; TCGA ESCA -0.176; TCGA HNSC -0.106; TCGA LUSC -0.261; TCGA OV -0.104; TCGA PRAD -0.218; TCGA SARC -0.155; TCGA STAD -0.214 |
hsa-miR-26a-5p | TCEA1 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.106; TCGA BRCA -0.12; TCGA ESCA -0.23; TCGA HNSC -0.147; TCGA LGG -0.078; TCGA LIHC -0.168; TCGA LUSC -0.297; TCGA OV -0.085; TCGA SARC -0.123; TCGA STAD -0.177; TCGA UCEC -0.169 |
hsa-miR-26a-5p | ARPP19 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.13; TCGA BRCA -0.113; TCGA CESC -0.092; TCGA COAD -0.119; TCGA ESCA -0.28; TCGA KIRC -0.098; TCGA SARC -0.262; TCGA STAD -0.395; TCGA UCEC -0.09 |
hsa-miR-26a-5p | HAPLN1 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.735; TCGA BRCA -1.064; TCGA CESC -0.801; TCGA HNSC -0.67; TCGA KIRC -1.342; TCGA LGG -0.596; TCGA LIHC -0.513; TCGA LUAD -0.447; TCGA LUSC -0.491; TCGA PAAD -0.791; TCGA THCA -1.525; TCGA UCEC -0.557 |
hsa-miR-26a-5p | BTBD7 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUSC; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.096; TCGA CESC -0.169; TCGA COAD -0.143; TCGA ESCA -0.261; TCGA KIRP -0.245; TCGA LUSC -0.207; TCGA SARC -0.094; TCGA STAD -0.223; TCGA UCEC -0.133 |
hsa-miR-26a-5p | AGPS | 10 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.139; TCGA CESC -0.169; TCGA COAD -0.124; TCGA ESCA -0.274; TCGA KIRP -0.318; TCGA LUAD -0.068; TCGA LUSC -0.242; TCGA PAAD -0.212; TCGA STAD -0.287; TCGA UCEC -0.212 |
hsa-miR-26a-5p | EXOC5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.112; TCGA BRCA -0.168; TCGA CESC -0.189; TCGA COAD -0.164; TCGA ESCA -0.393; TCGA HNSC -0.076; TCGA LGG -0.079; TCGA LUAD -0.067; TCGA LUSC -0.223; TCGA OV -0.103; TCGA SARC -0.093; TCGA STAD -0.286; TCGA UCEC -0.151 |
hsa-miR-26a-5p | YY1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.087; TCGA BRCA -0.155; TCGA CESC -0.085; TCGA COAD -0.115; TCGA ESCA -0.283; TCGA HNSC -0.134; TCGA LUAD -0.093; TCGA LUSC -0.391; TCGA PRAD -0.11; TCGA SARC -0.056; TCGA STAD -0.131; TCGA UCEC -0.079 |
hsa-miR-26a-5p | LONP2 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.108; TCGA BRCA -0.214; TCGA CESC -0.155; TCGA ESCA -0.179; TCGA KIRC -0.232; TCGA LUSC -0.196; TCGA PRAD -0.179; TCGA THCA -0.126; TCGA STAD -0.24; TCGA UCEC -0.115 |
hsa-miR-26a-5p | PCCB | 13 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.12; TCGA BRCA -0.157; TCGA COAD -0.209; TCGA ESCA -0.168; TCGA LGG -0.072; TCGA LUAD -0.114; TCGA LUSC -0.29; TCGA OV -0.089; TCGA PAAD -0.099; TCGA PRAD -0.443; TCGA SARC -0.058; TCGA THCA -0.247; TCGA STAD -0.133 |
hsa-miR-26a-5p | PANK3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.127; TCGA BRCA -0.301; TCGA CESC -0.202; TCGA COAD -0.294; TCGA ESCA -0.222; TCGA KIRC -0.25; TCGA LUAD -0.099; TCGA LUSC -0.397; TCGA OV -0.195; TCGA PRAD -0.277; TCGA SARC -0.074; TCGA STAD -0.259; TCGA UCEC -0.314 |
hsa-miR-26a-5p | KIF1C | 9 cancers: BLCA; CESC; COAD; KIRP; LIHC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.147; TCGA CESC -0.24; TCGA COAD -0.188; TCGA KIRP -0.111; TCGA LIHC -0.095; TCGA PAAD -0.262; TCGA PRAD -0.25; TCGA SARC -0.091; TCGA THCA -0.1 |
hsa-miR-26a-5p | MRPL35 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.1; TCGA BRCA -0.186; TCGA COAD -0.111; TCGA ESCA -0.109; TCGA KIRP -0.147; TCGA LIHC -0.067; TCGA LUAD -0.109; TCGA LUSC -0.329; TCGA PAAD -0.136; TCGA PRAD -0.12; TCGA SARC -0.092; TCGA UCEC -0.099 |
hsa-miR-26a-5p | NAV1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.258; TCGA BRCA -0.221; TCGA ESCA -0.574; TCGA HNSC -0.204; TCGA KIRC -0.188; TCGA LGG -0.245; TCGA LUAD -0.172; TCGA LUSC -0.556; TCGA STAD -0.234; TCGA UCEC -0.352 |
hsa-miR-26a-5p | SYNCRIP | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LGG; LUSC; PAAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.082; TCGA BRCA -0.158; TCGA CESC -0.091; TCGA ESCA -0.195; TCGA KIRP -0.07; TCGA LGG -0.067; TCGA LUSC -0.287; TCGA PAAD -0.109; TCGA STAD -0.247; TCGA UCEC -0.148 |
hsa-miR-26a-5p | RAB6B | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.303; TCGA KIRC -0.425; TCGA KIRP -0.57; TCGA LGG -0.088; TCGA LIHC -0.307; TCGA LUAD -0.211; TCGA LUSC -0.448; TCGA PRAD -0.353; TCGA THCA -0.107 |
hsa-miR-26a-5p | USP3 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.099; TCGA BRCA -0.145; TCGA CESC -0.108; TCGA COAD -0.203; TCGA KIRC -0.157; TCGA KIRP -0.088; TCGA LGG -0.199; TCGA PRAD -0.212; TCGA SARC -0.109; TCGA STAD -0.146; TCGA UCEC -0.161 |
hsa-miR-26a-5p | FBXO28 | 11 cancers: BLCA; BRCA; ESCA; KIRC; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.094; TCGA BRCA -0.197; TCGA ESCA -0.189; TCGA KIRC -0.15; TCGA LGG -0.09; TCGA LUSC -0.245; TCGA PAAD -0.141; TCGA PRAD -0.098; TCGA SARC -0.11; TCGA STAD -0.283; TCGA UCEC -0.216 |
hsa-miR-26a-5p | CLTC | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.116; TCGA BRCA -0.399; TCGA CESC -0.184; TCGA COAD -0.104; TCGA ESCA -0.225; TCGA LUAD -0.125; TCGA LUSC -0.206; TCGA PAAD -0.241; TCGA PRAD -0.173; TCGA THCA -0.08; TCGA STAD -0.181; TCGA UCEC -0.222 |
hsa-miR-26a-5p | ULK1 | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.175; TCGA BRCA -0.095; TCGA CESC -0.106; TCGA HNSC -0.279; TCGA LUAD -0.295; TCGA LUSC -0.402; TCGA PRAD -0.255; TCGA SARC -0.135; TCGA THCA -0.058 |
hsa-miR-26a-5p | ARF1 | 9 cancers: BLCA; BRCA; HNSC; LIHC; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.104; TCGA BRCA -0.193; TCGA HNSC -0.062; TCGA LIHC -0.156; TCGA LUSC -0.119; TCGA OV -0.11; TCGA PRAD -0.243; TCGA THCA -0.14; TCGA UCEC -0.148 |
hsa-miR-26a-5p | IPO7 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LUSC; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.143; TCGA BRCA -0.211; TCGA CESC -0.171; TCGA COAD -0.139; TCGA ESCA -0.178; TCGA KIRC -0.185; TCGA LGG -0.166; TCGA LUSC -0.223; TCGA PAAD -0.171; TCGA SARC -0.137; TCGA STAD -0.386; TCGA UCEC -0.165 |
hsa-miR-26a-5p | CARM1 | 9 cancers: BLCA; BRCA; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.161; TCGA ESCA -0.26; TCGA LIHC -0.137; TCGA LUAD -0.157; TCGA LUSC -0.37; TCGA PAAD -0.105; TCGA PRAD -0.154; TCGA THCA -0.12 |
hsa-miR-26a-5p | LSM11 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; SARC; STAD | miRNATAP | TCGA BLCA -0.189; TCGA BRCA -0.08; TCGA COAD -0.156; TCGA ESCA -0.157; TCGA KIRC -0.131; TCGA KIRP -0.149; TCGA LGG -0.072; TCGA LIHC -0.193; TCGA LUSC -0.138; TCGA PAAD -0.163; TCGA SARC -0.213; TCGA STAD -0.45 |
hsa-miR-26a-5p | LINGO1 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; THCA | miRNATAP | TCGA BLCA -0.364; TCGA BRCA -0.275; TCGA CESC -0.365; TCGA COAD -0.535; TCGA HNSC -0.163; TCGA LGG -0.39; TCGA LUAD -0.212; TCGA LUSC -0.502; TCGA THCA -0.405 |
hsa-miR-26a-5p | FAM98B | 9 cancers: BLCA; BRCA; ESCA; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.147; TCGA BRCA -0.172; TCGA ESCA -0.264; TCGA LUAD -0.096; TCGA LUSC -0.212; TCGA PRAD -0.14; TCGA SARC -0.218; TCGA STAD -0.263; TCGA UCEC -0.264 |
hsa-miR-26a-5p | PHF23 | 10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.101; TCGA BRCA -0.059; TCGA HNSC -0.183; TCGA LGG -0.053; TCGA LIHC -0.096; TCGA LUAD -0.081; TCGA LUSC -0.092; TCGA PRAD -0.188; TCGA THCA -0.151; TCGA UCEC -0.127 |
hsa-miR-26a-5p | CCNE1 | 15 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BRCA -0.619; TCGA CESC -0.185; TCGA ESCA -0.311; TCGA HNSC -0.491; TCGA KIRC -0.415; TCGA LIHC -0.599; TCGA LUAD -0.695; TCGA LUSC -1.322; TCGA OV -0.245; TCGA PAAD -0.384; TCGA PRAD -0.316; TCGA SARC -0.303; TCGA THCA -0.208; TCGA STAD -0.326; TCGA UCEC -0.288 |
hsa-miR-26a-5p | CCNE2 | 14 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BRCA -0.631; TCGA COAD -0.357; TCGA ESCA -0.436; TCGA KIRC -0.532; TCGA KIRP -0.302; TCGA LIHC -0.488; TCGA LUAD -0.51; TCGA LUSC -0.941; TCGA OV -0.401; TCGA PRAD -0.442; TCGA SARC -0.377; TCGA THCA -0.328; TCGA STAD -0.218; TCGA UCEC -0.62 |
hsa-miR-26a-5p | CDC6 | 16 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.676; TCGA CESC -0.176; TCGA COAD -0.392; TCGA ESCA -0.391; TCGA HNSC -0.327; TCGA KIRC -0.689; TCGA KIRP -0.672; TCGA LIHC -0.792; TCGA LUAD -0.731; TCGA LUSC -1.428; TCGA OV -0.335; TCGA PAAD -0.428; TCGA PRAD -0.534; TCGA SARC -0.145; TCGA THCA -0.464; TCGA UCEC -0.606 |
hsa-miR-26a-5p | CDK8 | 10 cancers: BRCA; CESC; LGG; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.288; TCGA CESC -0.257; TCGA LGG -0.151; TCGA LUAD -0.231; TCGA LUSC -0.352; TCGA OV -0.278; TCGA PAAD -0.183; TCGA SARC -0.212; TCGA STAD -0.331; TCGA UCEC -0.357 |
hsa-miR-26a-5p | COPB1 | 10 cancers: BRCA; CESC; COAD; KIRC; LGG; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.227; TCGA CESC -0.154; TCGA COAD -0.095; TCGA KIRC -0.128; TCGA LGG -0.051; TCGA LUSC -0.121; TCGA PAAD -0.158; TCGA PRAD -0.222; TCGA STAD -0.122; TCGA UCEC -0.141 |
hsa-miR-26a-5p | DHX15 | 10 cancers: BRCA; CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.162; TCGA CESC -0.103; TCGA COAD -0.178; TCGA ESCA -0.101; TCGA LUAD -0.106; TCGA LUSC -0.106; TCGA PRAD -0.216; TCGA SARC -0.073; TCGA STAD -0.155; TCGA UCEC -0.173 |
hsa-miR-26a-5p | DNMT1 | 10 cancers: BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.23; TCGA CESC -0.118; TCGA COAD -0.25; TCGA ESCA -0.307; TCGA LGG -0.1; TCGA LUAD -0.268; TCGA LUSC -0.367; TCGA SARC -0.114; TCGA STAD -0.186; TCGA UCEC -0.275 |
hsa-miR-26a-5p | E2F7 | 12 cancers: BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.622; TCGA COAD -0.307; TCGA ESCA -0.637; TCGA KIRC -0.827; TCGA LIHC -0.498; TCGA LUAD -0.461; TCGA LUSC -1.491; TCGA PAAD -0.483; TCGA SARC -0.352; TCGA THCA -0.549; TCGA STAD -0.354; TCGA UCEC -0.557 |
hsa-miR-26a-5p | EZH2 | 15 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BRCA -0.464; TCGA COAD -0.228; TCGA ESCA -0.207; TCGA KIRC -0.477; TCGA KIRP -0.505; TCGA LGG -0.292; TCGA LIHC -0.548; TCGA LUAD -0.552; TCGA LUSC -0.932; TCGA OV -0.211; TCGA PAAD -0.217; TCGA PRAD -0.556; TCGA SARC -0.309; TCGA THCA -0.276; TCGA UCEC -0.4 |
hsa-miR-26a-5p | GSK3B | 12 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.276; TCGA ESCA -0.297; TCGA KIRC -0.141; TCGA KIRP -0.222; TCGA LGG -0.124; TCGA LUAD -0.081; TCGA LUSC -0.285; TCGA PAAD -0.18; TCGA PRAD -0.115; TCGA SARC -0.113; TCGA STAD -0.276; TCGA UCEC -0.162 |
hsa-miR-26a-5p | HSPA8 | 9 cancers: BRCA; CESC; COAD; LUAD; LUSC; OV; PRAD; SARC; UCEC | miRNAWalker2 validate | TCGA BRCA -0.392; TCGA CESC -0.166; TCGA COAD -0.371; TCGA LUAD -0.114; TCGA LUSC -0.165; TCGA OV -0.096; TCGA PRAD -0.434; TCGA SARC -0.17; TCGA UCEC -0.2 |
hsa-miR-26a-5p | KCTD5 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.22; TCGA ESCA -0.177; TCGA HNSC -0.125; TCGA LGG -0.136; TCGA LUAD -0.119; TCGA LUSC -0.281; TCGA OV -0.076; TCGA PRAD -0.088; TCGA THCA -0.107; TCGA UCEC -0.128 |
hsa-miR-26a-5p | MRPL51 | 9 cancers: BRCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.114; TCGA HNSC -0.247; TCGA LIHC -0.191; TCGA LUAD -0.129; TCGA LUSC -0.368; TCGA OV -0.115; TCGA PRAD -0.297; TCGA SARC -0.056; TCGA THCA -0.158 |
hsa-miR-26a-5p | MSH6 | 10 cancers: BRCA; COAD; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BRCA -0.299; TCGA COAD -0.2; TCGA KIRC -0.101; TCGA LGG -0.058; TCGA LUAD -0.207; TCGA LUSC -0.487; TCGA PAAD -0.187; TCGA PRAD -0.083; TCGA SARC -0.076; TCGA STAD -0.185 |
hsa-miR-26a-5p | MTDH | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BRCA -0.212; TCGA CESC -0.098; TCGA COAD -0.134; TCGA ESCA -0.201; TCGA HNSC -0.093; TCGA KIRC -0.15; TCGA LIHC -0.199; TCGA LUSC -0.205; TCGA SARC -0.098; TCGA STAD -0.245; TCGA UCEC -0.118 |
hsa-miR-26a-5p | NUP205 | 11 cancers: BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.282; TCGA COAD -0.21; TCGA ESCA -0.339; TCGA KIRC -0.225; TCGA LGG -0.091; TCGA LIHC -0.091; TCGA LUAD -0.257; TCGA LUSC -0.513; TCGA SARC -0.095; TCGA STAD -0.305; TCGA UCEC -0.207 |
hsa-miR-26a-5p | PCYT1A | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.18; TCGA COAD -0.117; TCGA ESCA -0.376; TCGA HNSC -0.165; TCGA KIRC -0.188; TCGA LUAD -0.125; TCGA LUSC -0.54; TCGA PAAD -0.217; TCGA SARC -0.101 |
hsa-miR-26a-5p | PIGT | 10 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.198; TCGA CESC -0.117; TCGA HNSC -0.14; TCGA KIRP -0.174; TCGA LIHC -0.249; TCGA LUSC -0.296; TCGA OV -0.119; TCGA PRAD -0.209; TCGA THCA -0.11; TCGA UCEC -0.125 |
hsa-miR-26a-5p | PPIA | 11 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.171; TCGA HNSC -0.307; TCGA KIRP -0.248; TCGA LIHC -0.4; TCGA LUAD -0.12; TCGA LUSC -0.302; TCGA OV -0.2; TCGA PRAD -0.297; TCGA SARC -0.055; TCGA THCA -0.159; TCGA UCEC -0.206 |
hsa-miR-26a-5p | PSMA3 | 11 cancers: BRCA; COAD; ESCA; HNSC; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.167; TCGA COAD -0.141; TCGA ESCA -0.33; TCGA HNSC -0.228; TCGA LIHC -0.106; TCGA LUSC -0.323; TCGA OV -0.129; TCGA PRAD -0.366; TCGA SARC -0.101; TCGA THCA -0.152; TCGA UCEC -0.163 |
hsa-miR-26a-5p | PTTG1 | 9 cancers: BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PRAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.483; TCGA HNSC -0.365; TCGA KIRC -0.501; TCGA LIHC -1.015; TCGA LUAD -0.404; TCGA LUSC -0.968; TCGA OV -0.395; TCGA PRAD -0.471; TCGA UCEC -0.392 |
hsa-miR-26a-5p | RRM2 | 15 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.786; TCGA COAD -0.421; TCGA ESCA -0.416; TCGA HNSC -0.212; TCGA KIRC -0.777; TCGA LGG -0.304; TCGA LIHC -0.777; TCGA LUAD -0.684; TCGA LUSC -1.249; TCGA OV -0.36; TCGA PAAD -0.359; TCGA PRAD -0.799; TCGA SARC -0.16; TCGA THCA -0.273; TCGA UCEC -0.816 |
hsa-miR-26a-5p | SET | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUSC; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.161; TCGA COAD -0.11; TCGA ESCA -0.223; TCGA HNSC -0.066; TCGA KIRP -0.089; TCGA LGG -0.069; TCGA LUSC -0.317; TCGA OV -0.11; TCGA PRAD -0.142; TCGA STAD -0.121; TCGA UCEC -0.128 |
hsa-miR-26a-5p | SLC25A5 | 11 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.228; TCGA COAD -0.201; TCGA HNSC -0.068; TCGA LGG -0.103; TCGA LIHC -0.1; TCGA LUSC -0.339; TCGA OV -0.122; TCGA PRAD -0.349; TCGA SARC -0.089; TCGA THCA -0.227; TCGA UCEC -0.261 |
hsa-miR-26a-5p | TBC1D16 | 9 cancers: BRCA; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.102; TCGA LIHC -0.359; TCGA LUAD -0.291; TCGA LUSC -0.19; TCGA OV -0.211; TCGA PAAD -0.326; TCGA PRAD -0.354; TCGA STAD -0.227; TCGA UCEC -0.135 |
hsa-miR-26a-5p | TKT | 11 cancers: BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.106; TCGA ESCA -0.298; TCGA HNSC -0.148; TCGA KIRP -0.236; TCGA LIHC -0.79; TCGA LUAD -0.174; TCGA LUSC -0.319; TCGA PAAD -0.197; TCGA PRAD -0.367; TCGA THCA -0.339; TCGA UCEC -0.23 |
hsa-miR-26a-5p | TXLNG | 9 cancers: BRCA; CESC; COAD; KIRC; LGG; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.181; TCGA CESC -0.218; TCGA COAD -0.268; TCGA KIRC -0.226; TCGA LGG -0.126; TCGA LUSC -0.187; TCGA SARC -0.313; TCGA STAD -0.302; TCGA UCEC -0.211 |
hsa-miR-26a-5p | UBE2A | 9 cancers: BRCA; ESCA; HNSC; LIHC; LUSC; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.219; TCGA ESCA -0.158; TCGA HNSC -0.082; TCGA LIHC -0.194; TCGA LUSC -0.185; TCGA PRAD -0.143; TCGA SARC -0.056; TCGA THCA -0.268; TCGA UCEC -0.116 |
hsa-miR-26a-5p | ZNF207 | 12 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.105; TCGA CESC -0.076; TCGA ESCA -0.133; TCGA KIRC -0.115; TCGA KIRP -0.102; TCGA LGG -0.056; TCGA LIHC -0.115; TCGA LUSC -0.215; TCGA PRAD -0.121; TCGA SARC -0.056; TCGA STAD -0.078; TCGA UCEC -0.16 |
hsa-miR-26a-5p | PRRC1 | 10 cancers: BRCA; CESC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.203; TCGA CESC -0.116; TCGA KIRC -0.216; TCGA LGG -0.114; TCGA LIHC -0.07; TCGA LUSC -0.076; TCGA PAAD -0.149; TCGA PRAD -0.162; TCGA STAD -0.106; TCGA UCEC -0.125 |
hsa-miR-26a-5p | NAA15 | 9 cancers: BRCA; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.259; TCGA COAD -0.134; TCGA ESCA -0.23; TCGA KIRC -0.111; TCGA LUAD -0.165; TCGA LUSC -0.302; TCGA SARC -0.165; TCGA STAD -0.211; TCGA UCEC -0.219 |
hsa-miR-26a-5p | ABL2 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.142; TCGA CESC -0.143; TCGA ESCA -0.309; TCGA HNSC -0.21; TCGA KIRC -0.151; TCGA LGG -0.143; TCGA LUSC -0.138; TCGA STAD -0.316; TCGA UCEC -0.095 |
hsa-miR-26a-5p | COL1A2 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD | MirTarget; miRNATAP | TCGA BRCA -0.442; TCGA CESC -0.354; TCGA COAD -0.639; TCGA ESCA -0.593; TCGA HNSC -0.368; TCGA LUAD -0.254; TCGA LUSC -0.279; TCGA PAAD -0.804; TCGA STAD -0.439 |
hsa-miR-26a-5p | FAM120A | 10 cancers: BRCA; CESC; ESCA; KIRC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.126; TCGA CESC -0.081; TCGA ESCA -0.247; TCGA KIRC -0.095; TCGA LUSC -0.228; TCGA PAAD -0.172; TCGA PRAD -0.106; TCGA THCA -0.069; TCGA STAD -0.189; TCGA UCEC -0.127 |
hsa-miR-26a-5p | TWF1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.152; TCGA ESCA -0.254; TCGA HNSC -0.089; TCGA KIRC -0.154; TCGA LUAD -0.139; TCGA LUSC -0.53; TCGA THCA -0.205; TCGA STAD -0.341; TCGA UCEC -0.17 |
hsa-miR-26a-5p | NUS1 | 9 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUSC; OV; SARC; STAD | MirTarget; miRNATAP | TCGA BRCA -0.124; TCGA CESC -0.116; TCGA ESCA -0.152; TCGA HNSC -0.098; TCGA LGG -0.07; TCGA LUSC -0.165; TCGA OV -0.077; TCGA SARC -0.143; TCGA STAD -0.223 |
hsa-miR-26a-5p | SFPQ | 9 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.159; TCGA COAD -0.091; TCGA ESCA -0.166; TCGA HNSC -0.088; TCGA LUAD -0.1; TCGA LUSC -0.254; TCGA PRAD -0.196; TCGA STAD -0.126; TCGA UCEC -0.15 |
hsa-miR-26a-5p | OTUD6B | 11 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.124; TCGA ESCA -0.401; TCGA HNSC -0.088; TCGA LGG -0.077; TCGA LIHC -0.254; TCGA LUAD -0.161; TCGA LUSC -0.307; TCGA PRAD -0.191; TCGA SARC -0.139; TCGA STAD -0.438; TCGA UCEC -0.226 |
hsa-miR-26a-5p | TMEM189 | 11 cancers: BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.171; TCGA ESCA -0.35; TCGA HNSC -0.357; TCGA LIHC -0.207; TCGA LUAD -0.165; TCGA LUSC -0.581; TCGA OV -0.229; TCGA PAAD -0.276; TCGA SARC -0.142; TCGA THCA -0.207; TCGA UCEC -0.166 |
hsa-miR-26a-5p | LSM12 | 12 cancers: BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.102; TCGA ESCA -0.176; TCGA HNSC -0.086; TCGA LIHC -0.139; TCGA LUAD -0.116; TCGA LUSC -0.344; TCGA OV -0.134; TCGA PRAD -0.126; TCGA SARC -0.121; TCGA THCA -0.123; TCGA STAD -0.21; TCGA UCEC -0.182 |
hsa-miR-26a-5p | PHTF2 | 10 cancers: BRCA; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; SARC; STAD | MirTarget; miRNATAP | TCGA BRCA -0.25; TCGA ESCA -0.301; TCGA KIRC -0.134; TCGA LGG -0.096; TCGA LIHC -0.1; TCGA LUAD -0.162; TCGA LUSC -0.261; TCGA OV -0.117; TCGA SARC -0.172; TCGA STAD -0.38 |
hsa-miR-26a-5p | BARD1 | 9 cancers: BRCA; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.361; TCGA COAD -0.505; TCGA ESCA -0.297; TCGA KIRC -0.287; TCGA LUAD -0.251; TCGA LUSC -0.49; TCGA SARC -0.379; TCGA STAD -0.398; TCGA UCEC -0.453 |
hsa-miR-26a-5p | PAK2 | 9 cancers: BRCA; ESCA; KIRC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.188; TCGA ESCA -0.273; TCGA KIRC -0.161; TCGA LGG -0.072; TCGA LUAD -0.079; TCGA LUSC -0.392; TCGA PAAD -0.15; TCGA STAD -0.167; TCGA UCEC -0.105 |
hsa-miR-26a-5p | RCN2 | 13 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.176; TCGA COAD -0.141; TCGA HNSC -0.102; TCGA KIRP -0.097; TCGA LGG -0.081; TCGA LIHC -0.142; TCGA LUSC -0.423; TCGA PAAD -0.207; TCGA PRAD -0.355; TCGA SARC -0.056; TCGA THCA -0.298; TCGA STAD -0.235; TCGA UCEC -0.301 |
hsa-miR-26a-5p | TNPO1 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BRCA -0.173; TCGA CESC -0.104; TCGA COAD -0.138; TCGA ESCA -0.169; TCGA KIRC -0.124; TCGA LUAD -0.104; TCGA LUSC -0.282; TCGA STAD -0.231; TCGA UCEC -0.154 |
hsa-miR-26a-5p | KPNA2 | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.576; TCGA CESC -0.235; TCGA COAD -0.309; TCGA ESCA -0.489; TCGA HNSC -0.297; TCGA LIHC -0.42; TCGA LUAD -0.503; TCGA LUSC -0.884; TCGA OV -0.287; TCGA PAAD -0.314; TCGA PRAD -0.52; TCGA SARC -0.105; TCGA THCA -0.169; TCGA UCEC -0.548 |
hsa-miR-26a-5p | ATAD2 | 15 cancers: BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.472; TCGA CESC -0.142; TCGA COAD -0.249; TCGA ESCA -0.445; TCGA KIRC -0.36; TCGA LGG -0.077; TCGA LIHC -0.345; TCGA LUAD -0.405; TCGA LUSC -0.79; TCGA OV -0.266; TCGA PRAD -0.174; TCGA SARC -0.261; TCGA THCA -0.111; TCGA STAD -0.446; TCGA UCEC -0.314 |
hsa-miR-26a-5p | ZNF598 | 11 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget | TCGA BRCA -0.114; TCGA ESCA -0.198; TCGA HNSC -0.243; TCGA KIRP -0.148; TCGA LGG -0.115; TCGA LIHC -0.12; TCGA LUAD -0.268; TCGA LUSC -0.365; TCGA PRAD -0.306; TCGA SARC -0.063; TCGA THCA -0.121 |
hsa-miR-26a-5p | ABHD5 | 10 cancers: BRCA; CESC; KIRP; LGG; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.093; TCGA CESC -0.12; TCGA KIRP -0.098; TCGA LGG -0.063; TCGA OV -0.089; TCGA PAAD -0.154; TCGA PRAD -0.137; TCGA SARC -0.072; TCGA THCA -0.106; TCGA UCEC -0.33 |
hsa-miR-26a-5p | SRP19 | 9 cancers: BRCA; HNSC; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.103; TCGA HNSC -0.137; TCGA LIHC -0.204; TCGA LUSC -0.093; TCGA OV -0.101; TCGA PRAD -0.281; TCGA SARC -0.095; TCGA THCA -0.115; TCGA UCEC -0.102 |
hsa-miR-26a-5p | DLG5 | 11 cancers: BRCA; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.17; TCGA ESCA -0.319; TCGA KIRC -0.282; TCGA LGG -0.296; TCGA LIHC -0.425; TCGA LUAD -0.255; TCGA LUSC -0.597; TCGA PAAD -0.342; TCGA SARC -0.157; TCGA STAD -0.375; TCGA UCEC -0.221 |
hsa-miR-26a-5p | FLVCR1 | 10 cancers: BRCA; CESC; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.42; TCGA CESC -0.193; TCGA KIRC -0.254; TCGA LGG -0.171; TCGA LIHC -0.606; TCGA LUAD -0.171; TCGA LUSC -0.589; TCGA PRAD -0.308; TCGA SARC -0.189; TCGA UCEC -0.311 |
hsa-miR-26a-5p | SFXN1 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.291; TCGA COAD -0.247; TCGA ESCA -0.225; TCGA HNSC -0.108; TCGA KIRC -0.235; TCGA LGG -0.191; TCGA LUAD -0.247; TCGA LUSC -0.765; TCGA OV -0.175; TCGA PRAD -0.141; TCGA THCA -0.067; TCGA STAD -0.149; TCGA UCEC -0.192 |
hsa-miR-26a-5p | BLOC1S2 | 9 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUSC; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.085; TCGA ESCA -0.161; TCGA HNSC -0.108; TCGA LGG -0.076; TCGA LIHC -0.093; TCGA LUSC -0.107; TCGA PRAD -0.137; TCGA THCA -0.218; TCGA UCEC -0.125 |
hsa-miR-26a-5p | TTPAL | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.149; TCGA CESC -0.176; TCGA ESCA -0.402; TCGA HNSC -0.378; TCGA KIRC -0.202; TCGA KIRP -0.112; TCGA LGG -0.113; TCGA LUAD -0.114; TCGA LUSC -0.438; TCGA SARC -0.163; TCGA STAD -0.303; TCGA UCEC -0.119 |
hsa-miR-26a-5p | G2E3 | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; LUSC; OV; STAD; UCEC | MirTarget | TCGA BRCA -0.176; TCGA CESC -0.175; TCGA COAD -0.282; TCGA ESCA -0.287; TCGA LGG -0.064; TCGA LUSC -0.406; TCGA OV -0.112; TCGA STAD -0.327; TCGA UCEC -0.114 |
hsa-miR-26a-5p | TRIM65 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BRCA -0.09; TCGA COAD -0.152; TCGA ESCA -0.249; TCGA HNSC -0.132; TCGA KIRP -0.148; TCGA LGG -0.08; TCGA LIHC -0.341; TCGA LUAD -0.158; TCGA LUSC -0.228; TCGA PAAD -0.176; TCGA PRAD -0.222; TCGA SARC -0.145; TCGA THCA -0.125 |
hsa-miR-26a-5p | MAPK6 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.253; TCGA CESC -0.177; TCGA COAD -0.214; TCGA ESCA -0.509; TCGA HNSC -0.259; TCGA KIRC -0.243; TCGA KIRP -0.116; TCGA LUAD -0.228; TCGA LUSC -0.688; TCGA OV -0.116; TCGA PAAD -0.183; TCGA PRAD -0.252; TCGA SARC -0.183; TCGA STAD -0.125; TCGA UCEC -0.273 |
hsa-miR-26a-5p | TMEM68 | 11 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.152; TCGA ESCA -0.272; TCGA HNSC -0.144; TCGA LGG -0.069; TCGA LIHC -0.265; TCGA LUSC -0.248; TCGA PRAD -0.113; TCGA SARC -0.087; TCGA THCA -0.137; TCGA STAD -0.316; TCGA UCEC -0.119 |
hsa-miR-26a-5p | UGGT1 | 11 cancers: BRCA; CESC; COAD; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.248; TCGA CESC -0.161; TCGA COAD -0.172; TCGA KIRC -0.179; TCGA LIHC -0.285; TCGA LUAD -0.14; TCGA LUSC -0.358; TCGA PAAD -0.202; TCGA PRAD -0.138; TCGA STAD -0.209; TCGA UCEC -0.236 |
hsa-miR-26a-5p | TMEM184B | 11 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.147; TCGA CESC -0.185; TCGA ESCA -0.173; TCGA HNSC -0.194; TCGA LIHC -0.138; TCGA LUAD -0.183; TCGA LUSC -0.216; TCGA PAAD -0.287; TCGA PRAD -0.149; TCGA THCA -0.125; TCGA UCEC -0.222 |
hsa-miR-26a-5p | LMLN | 9 cancers: BRCA; ESCA; KIRC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.181; TCGA ESCA -0.311; TCGA KIRC -0.273; TCGA KIRP -0.345; TCGA LUSC -0.344; TCGA PAAD -0.236; TCGA PRAD -0.147; TCGA STAD -0.413; TCGA UCEC -0.194 |
hsa-miR-26a-5p | UBE2H | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.226; TCGA CESC -0.125; TCGA ESCA -0.25; TCGA KIRC -0.249; TCGA KIRP -0.199; TCGA LUAD -0.134; TCGA LUSC -0.298; TCGA PAAD -0.187; TCGA STAD -0.235; TCGA UCEC -0.222 |
hsa-miR-26a-5p | ZNF410 | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.107; TCGA COAD -0.173; TCGA ESCA -0.149; TCGA HNSC -0.147; TCGA KIRP -0.063; TCGA LGG -0.074; TCGA LUSC -0.119; TCGA OV -0.125; TCGA PRAD -0.074; TCGA SARC -0.077; TCGA UCEC -0.062 |
hsa-miR-26a-5p | CHORDC1 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.202; TCGA CESC -0.276; TCGA COAD -0.202; TCGA ESCA -0.425; TCGA HNSC -0.293; TCGA LGG -0.084; TCGA LIHC -0.116; TCGA LUAD -0.251; TCGA LUSC -0.524; TCGA OV -0.145; TCGA PRAD -0.186; TCGA SARC -0.162; TCGA STAD -0.347 |
hsa-miR-26a-5p | UHRF1BP1 | 10 cancers: BRCA; COAD; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.236; TCGA COAD -0.139; TCGA KIRC -0.179; TCGA LGG -0.115; TCGA LIHC -0.109; TCGA LUAD -0.126; TCGA LUSC -0.099; TCGA PRAD -0.189; TCGA STAD -0.255; TCGA UCEC -0.175 |
hsa-miR-26a-5p | DEPDC1 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.8; TCGA CESC -0.256; TCGA COAD -0.451; TCGA ESCA -0.456; TCGA HNSC -0.225; TCGA KIRC -0.818; TCGA LIHC -0.876; TCGA LUAD -0.72; TCGA LUSC -1.546; TCGA OV -0.376; TCGA PAAD -0.395; TCGA PRAD -0.392; TCGA SARC -0.233; TCGA STAD -0.354; TCGA UCEC -0.658 |
hsa-miR-26a-5p | ASCC3 | 12 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.247; TCGA CESC -0.199; TCGA COAD -0.12; TCGA ESCA -0.242; TCGA KIRC -0.264; TCGA KIRP -0.189; TCGA LGG -0.154; TCGA LUSC -0.27; TCGA PAAD -0.148; TCGA THCA -0.111; TCGA STAD -0.27; TCGA UCEC -0.194 |
hsa-miR-26a-5p | DEPDC1B | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.683; TCGA CESC -0.197; TCGA COAD -0.303; TCGA ESCA -0.321; TCGA HNSC -0.297; TCGA LGG -0.155; TCGA LIHC -0.548; TCGA LUAD -0.608; TCGA LUSC -1.41; TCGA OV -0.446; TCGA PRAD -0.721; TCGA SARC -0.153; TCGA UCEC -0.722 |
hsa-miR-26a-5p | PAWR | 10 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BRCA -0.148; TCGA COAD -0.128; TCGA ESCA -0.424; TCGA HNSC -0.216; TCGA LUAD -0.269; TCGA LUSC -0.502; TCGA PRAD -0.149; TCGA SARC -0.57; TCGA STAD -0.295; TCGA UCEC -0.13 |
hsa-miR-26a-5p | METAP2 | 9 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.13; TCGA COAD -0.14; TCGA ESCA -0.131; TCGA HNSC -0.114; TCGA LGG -0.079; TCGA LUSC -0.127; TCGA PRAD -0.108; TCGA STAD -0.132; TCGA UCEC -0.127 |
hsa-miR-26a-5p | FAM98A | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.199; TCGA CESC -0.118; TCGA COAD -0.108; TCGA ESCA -0.209; TCGA HNSC -0.086; TCGA KIRP -0.169; TCGA LIHC -0.141; TCGA LUAD -0.162; TCGA LUSC -0.293; TCGA PAAD -0.185; TCGA PRAD -0.238; TCGA STAD -0.184; TCGA UCEC -0.106 |
hsa-miR-26a-5p | PHF6 | 9 cancers: BRCA; ESCA; KIRC; LGG; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; mirMAP; miRNATAP | TCGA BRCA -0.2; TCGA ESCA -0.145; TCGA KIRC -0.171; TCGA LGG -0.199; TCGA LUAD -0.131; TCGA LUSC -0.339; TCGA SARC -0.14; TCGA STAD -0.359; TCGA UCEC -0.215 |
hsa-miR-26a-5p | TMX1 | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.093; TCGA COAD -0.203; TCGA ESCA -0.403; TCGA HNSC -0.136; TCGA KIRC -0.136; TCGA LUSC -0.337; TCGA OV -0.086; TCGA SARC -0.105; TCGA STAD -0.179; TCGA UCEC -0.136 |
hsa-miR-26a-5p | SLC33A1 | 9 cancers: BRCA; COAD; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.187; TCGA COAD -0.153; TCGA KIRC -0.193; TCGA LUAD -0.086; TCGA LUSC -0.416; TCGA PAAD -0.221; TCGA PRAD -0.175; TCGA SARC -0.112; TCGA STAD -0.098 |
hsa-miR-26a-5p | SKP2 | 12 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.325; TCGA CESC -0.154; TCGA COAD -0.355; TCGA ESCA -0.241; TCGA KIRC -0.215; TCGA LUAD -0.345; TCGA LUSC -0.817; TCGA OV -0.26; TCGA PAAD -0.345; TCGA SARC -0.143; TCGA STAD -0.404; TCGA UCEC -0.358 |
hsa-miR-26a-5p | RLF | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUSC; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.088; TCGA CESC -0.149; TCGA COAD -0.178; TCGA ESCA -0.178; TCGA KIRC -0.145; TCGA LUSC -0.113; TCGA SARC -0.1; TCGA STAD -0.33; TCGA UCEC -0.11 |
hsa-miR-26a-5p | FAM136A | 13 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.186; TCGA CESC -0.102; TCGA HNSC -0.179; TCGA KIRP -0.162; TCGA LIHC -0.182; TCGA LUAD -0.228; TCGA LUSC -0.441; TCGA OV -0.113; TCGA PAAD -0.147; TCGA PRAD -0.33; TCGA SARC -0.058; TCGA THCA -0.119; TCGA UCEC -0.191 |
hsa-miR-26a-5p | FEN1 | 14 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.357; TCGA COAD -0.266; TCGA HNSC -0.251; TCGA KIRC -0.137; TCGA LGG -0.098; TCGA LIHC -0.353; TCGA LUAD -0.359; TCGA LUSC -0.771; TCGA OV -0.206; TCGA PAAD -0.267; TCGA PRAD -0.388; TCGA SARC -0.344; TCGA THCA -0.125; TCGA UCEC -0.373 |
hsa-miR-26a-5p | SENP5 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC; STAD | MirTarget; miRNATAP | TCGA BRCA -0.119; TCGA ESCA -0.22; TCGA HNSC -0.123; TCGA KIRC -0.127; TCGA KIRP -0.082; TCGA LGG -0.061; TCGA LUAD -0.126; TCGA LUSC -0.477; TCGA SARC -0.108; TCGA STAD -0.326 |
hsa-miR-26a-5p | PDHX | 12 cancers: BRCA; CESC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.173; TCGA CESC -0.123; TCGA LGG -0.094; TCGA LUAD -0.086; TCGA LUSC -0.339; TCGA OV -0.13; TCGA PAAD -0.11; TCGA PRAD -0.236; TCGA SARC -0.133; TCGA THCA -0.083; TCGA STAD -0.102; TCGA UCEC -0.234 |
hsa-miR-26a-5p | REEP4 | 11 cancers: BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.246; TCGA ESCA -0.219; TCGA HNSC -0.316; TCGA KIRP -0.133; TCGA LIHC -0.262; TCGA LUAD -0.183; TCGA LUSC -0.536; TCGA OV -0.205; TCGA SARC -0.061; TCGA THCA -0.216; TCGA UCEC -0.256 |
hsa-miR-26a-5p | HMGB3 | 12 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.615; TCGA ESCA -0.301; TCGA HNSC -0.361; TCGA KIRP -0.625; TCGA LGG -0.171; TCGA LUAD -0.286; TCGA LUSC -0.792; TCGA OV -0.307; TCGA PRAD -0.37; TCGA THCA -0.218; TCGA STAD -0.277; TCGA UCEC -0.334 |
hsa-miR-26a-5p | MTHFD2 | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.371; TCGA CESC -0.126; TCGA COAD -0.401; TCGA HNSC -0.098; TCGA LGG -0.4; TCGA LUAD -0.352; TCGA LUSC -0.623; TCGA PRAD -0.388; TCGA SARC -0.127; TCGA UCEC -0.198 |
hsa-miR-26a-5p | HES2 | 9 cancers: BRCA; ESCA; HNSC; LIHC; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.259; TCGA ESCA -1.269; TCGA HNSC -0.613; TCGA LIHC -0.397; TCGA LUSC -1.031; TCGA PAAD -0.979; TCGA THCA -0.597; TCGA STAD -0.803; TCGA UCEC -0.49 |
hsa-miR-26a-5p | CSNK2A1 | 10 cancers: BRCA; CESC; COAD; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; UCEC | mirMAP | TCGA BRCA -0.183; TCGA CESC -0.109; TCGA COAD -0.155; TCGA KIRC -0.177; TCGA KIRP -0.123; TCGA LGG -0.083; TCGA LUAD -0.087; TCGA LUSC -0.428; TCGA PRAD -0.11; TCGA UCEC -0.119 |
hsa-miR-26a-5p | AMMECR1 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.237; TCGA CESC -0.149; TCGA ESCA -0.348; TCGA HNSC -0.169; TCGA KIRC -0.15; TCGA KIRP -0.207; TCGA LUAD -0.084; TCGA LUSC -0.527; TCGA OV -0.126; TCGA UCEC -0.306 |
hsa-miR-26a-5p | IMPAD1 | 13 cancers: BRCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.184; TCGA CESC -0.113; TCGA ESCA -0.162; TCGA KIRC -0.159; TCGA LIHC -0.132; TCGA LUAD -0.079; TCGA LUSC -0.163; TCGA PAAD -0.166; TCGA PRAD -0.092; TCGA SARC -0.069; TCGA THCA -0.057; TCGA STAD -0.258; TCGA UCEC -0.138 |
hsa-miR-26a-5p | AVL9 | 11 cancers: BRCA; CESC; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.297; TCGA CESC -0.164; TCGA HNSC -0.111; TCGA KIRC -0.287; TCGA LIHC -0.108; TCGA LUAD -0.212; TCGA LUSC -0.468; TCGA PAAD -0.192; TCGA SARC -0.132; TCGA STAD -0.23; TCGA UCEC -0.306 |
hsa-miR-26a-5p | GTPBP10 | 10 cancers: BRCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.073; TCGA KIRC -0.132; TCGA KIRP -0.171; TCGA LGG -0.074; TCGA LIHC -0.115; TCGA LUSC -0.319; TCGA PRAD -0.132; TCGA SARC -0.091; TCGA STAD -0.307; TCGA UCEC -0.085 |
hsa-miR-26a-5p | RAD1 | 10 cancers: BRCA; COAD; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.233; TCGA COAD -0.122; TCGA LIHC -0.156; TCGA LUSC -0.274; TCGA OV -0.243; TCGA PAAD -0.106; TCGA PRAD -0.154; TCGA SARC -0.075; TCGA STAD -0.136; TCGA UCEC -0.114 |
hsa-miR-26a-5p | NUP155 | 11 cancers: BRCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.402; TCGA CESC -0.163; TCGA ESCA -0.185; TCGA KIRC -0.269; TCGA LGG -0.091; TCGA LUAD -0.293; TCGA LUSC -0.689; TCGA PAAD -0.187; TCGA SARC -0.161; TCGA STAD -0.441; TCGA UCEC -0.264 |
hsa-miR-26a-5p | KPNA1 | 11 cancers: BRCA; ESCA; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.228; TCGA ESCA -0.275; TCGA KIRP -0.104; TCGA LUAD -0.116; TCGA LUSC -0.359; TCGA OV -0.098; TCGA PAAD -0.142; TCGA PRAD -0.169; TCGA SARC -0.08; TCGA THCA -0.092; TCGA STAD -0.23 |
hsa-miR-26a-5p | COMMD2 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUSC; OV; PAAD; STAD | mirMAP | TCGA BRCA -0.083; TCGA ESCA -0.194; TCGA KIRC -0.101; TCGA KIRP -0.202; TCGA LGG -0.065; TCGA LUSC -0.161; TCGA OV -0.113; TCGA PAAD -0.139; TCGA STAD -0.171 |
hsa-miR-26a-5p | RAD23B | 11 cancers: BRCA; CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.184; TCGA CESC -0.084; TCGA COAD -0.128; TCGA ESCA -0.282; TCGA LUAD -0.084; TCGA LUSC -0.33; TCGA PRAD -0.237; TCGA SARC -0.051; TCGA THCA -0.149; TCGA STAD -0.226; TCGA UCEC -0.164 |
hsa-miR-26a-5p | TRIM24 | 9 cancers: BRCA; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.234; TCGA KIRP -0.177; TCGA LGG -0.168; TCGA LIHC -0.165; TCGA LUSC -0.301; TCGA PRAD -0.172; TCGA SARC -0.056; TCGA THCA -0.157; TCGA UCEC -0.162 |
hsa-miR-26a-5p | FAM199X | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.217; TCGA CESC -0.108; TCGA COAD -0.161; TCGA ESCA -0.142; TCGA KIRC -0.258; TCGA LUAD -0.15; TCGA LUSC -0.433; TCGA PRAD -0.198; TCGA SARC -0.115; TCGA STAD -0.267; TCGA UCEC -0.372 |
hsa-miR-26a-5p | VAPB | 11 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; UCEC | mirMAP | TCGA BRCA -0.208; TCGA CESC -0.107; TCGA HNSC -0.126; TCGA KIRP -0.112; TCGA LIHC -0.07; TCGA LUAD -0.109; TCGA LUSC -0.24; TCGA OV -0.15; TCGA PAAD -0.122; TCGA PRAD -0.219; TCGA UCEC -0.116 |
hsa-miR-26a-5p | RAB22A | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.165; TCGA ESCA -0.199; TCGA HNSC -0.232; TCGA KIRC -0.172; TCGA KIRP -0.093; TCGA LUSC -0.239; TCGA OV -0.067; TCGA PRAD -0.079; TCGA THCA -0.055; TCGA STAD -0.198 |
hsa-miR-26a-5p | GTF3C4 | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.257; TCGA CESC -0.195; TCGA COAD -0.285; TCGA ESCA -0.276; TCGA LGG -0.116; TCGA LUSC -0.306; TCGA PAAD -0.176; TCGA STAD -0.309; TCGA UCEC -0.173 |
hsa-miR-26a-5p | SLC35E1 | 9 cancers: BRCA; CESC; KIRC; LIHC; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BRCA -0.168; TCGA CESC -0.165; TCGA KIRC -0.195; TCGA LIHC -0.068; TCGA LUSC -0.141; TCGA PAAD -0.122; TCGA PRAD -0.317; TCGA SARC -0.053; TCGA THCA -0.074 |
hsa-miR-26a-5p | GRSF1 | 11 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.163; TCGA COAD -0.137; TCGA HNSC -0.094; TCGA KIRC -0.105; TCGA KIRP -0.126; TCGA LUAD -0.078; TCGA LUSC -0.12; TCGA PRAD -0.264; TCGA THCA -0.086; TCGA STAD -0.093; TCGA UCEC -0.167 |
hsa-miR-26a-5p | POM121C | 11 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.08; TCGA ESCA -0.243; TCGA KIRC -0.221; TCGA KIRP -0.114; TCGA LGG -0.061; TCGA LIHC -0.074; TCGA LUAD -0.074; TCGA LUSC -0.289; TCGA PRAD -0.132; TCGA STAD -0.175; TCGA UCEC -0.16 |
hsa-miR-26a-5p | ANKRD52 | 9 cancers: BRCA; CESC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.172; TCGA CESC -0.11; TCGA LIHC -0.378; TCGA LUAD -0.188; TCGA LUSC -0.249; TCGA PRAD -0.278; TCGA SARC -0.107; TCGA STAD -0.147; TCGA UCEC -0.158 |
hsa-miR-26a-5p | SBNO1 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.345; TCGA CESC -0.423; TCGA COAD -0.326; TCGA ESCA -0.193; TCGA KIRC -0.316; TCGA LUAD -0.199; TCGA LUSC -0.422; TCGA SARC -0.266; TCGA STAD -0.402; TCGA UCEC -0.331 |
hsa-miR-26a-5p | AMMECR1L | 10 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.096; TCGA CESC -0.073; TCGA ESCA -0.17; TCGA HNSC -0.087; TCGA LGG -0.103; TCGA LUAD -0.068; TCGA LUSC -0.19; TCGA PAAD -0.097; TCGA STAD -0.189; TCGA UCEC -0.059 |
hsa-miR-26a-5p | G3BP1 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; UCEC | mirMAP | TCGA BRCA -0.211; TCGA CESC -0.092; TCGA COAD -0.183; TCGA ESCA -0.221; TCGA KIRC -0.166; TCGA LUAD -0.09; TCGA LUSC -0.347; TCGA PRAD -0.143; TCGA UCEC -0.142 |
hsa-miR-26a-5p | PURB | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; SARC; STAD | mirMAP | TCGA BRCA -0.113; TCGA ESCA -0.251; TCGA HNSC -0.092; TCGA KIRC -0.114; TCGA KIRP -0.182; TCGA LGG -0.069; TCGA LUSC -0.293; TCGA SARC -0.098; TCGA STAD -0.409 |
hsa-miR-26a-5p | ADAM12 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP; miRNATAP | TCGA BRCA -0.374; TCGA CESC -0.418; TCGA COAD -0.594; TCGA ESCA -0.859; TCGA HNSC -0.463; TCGA KIRC -0.567; TCGA LUAD -0.506; TCGA LUSC -1.068; TCGA PAAD -0.817; TCGA THCA -0.38; TCGA STAD -0.482 |
hsa-miR-26a-5p | CELF1 | 9 cancers: BRCA; CESC; ESCA; LGG; LUAD; LUSC; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.112; TCGA CESC -0.143; TCGA ESCA -0.186; TCGA LGG -0.07; TCGA LUAD -0.099; TCGA LUSC -0.162; TCGA SARC -0.167; TCGA STAD -0.269; TCGA UCEC -0.094 |
hsa-miR-26a-5p | SPOCK1 | 9 cancers: BRCA; COAD; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.286; TCGA COAD -0.711; TCGA LUAD -0.526; TCGA LUSC -0.704; TCGA OV -0.402; TCGA PAAD -0.681; TCGA PRAD -0.669; TCGA THCA -0.41; TCGA STAD -0.814 |
hsa-miR-26a-5p | C16orf87 | 9 cancers: BRCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.2; TCGA HNSC -0.241; TCGA LGG -0.173; TCGA LUAD -0.117; TCGA LUSC -0.258; TCGA OV -0.288; TCGA PRAD -0.339; TCGA STAD -0.223; TCGA UCEC -0.219 |
hsa-miR-26a-5p | VMA21 | 11 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; SARC; STAD | mirMAP; miRNATAP | TCGA BRCA -0.112; TCGA ESCA -0.237; TCGA HNSC -0.078; TCGA KIRC -0.135; TCGA KIRP -0.102; TCGA LGG -0.135; TCGA LIHC -0.075; TCGA LUSC -0.363; TCGA OV -0.107; TCGA SARC -0.171; TCGA STAD -0.482 |
hsa-miR-26a-5p | TAOK1 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUSC; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.338; TCGA CESC -0.313; TCGA COAD -0.367; TCGA ESCA -0.267; TCGA KIRC -0.332; TCGA LUSC -0.157; TCGA SARC -0.21; TCGA STAD -0.383; TCGA UCEC -0.265 |
hsa-miR-26a-5p | GMPS | 13 cancers: BRCA; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.324; TCGA ESCA -0.255; TCGA HNSC -0.122; TCGA KIRC -0.16; TCGA LIHC -0.118; TCGA LUAD -0.211; TCGA LUSC -0.706; TCGA OV -0.165; TCGA PAAD -0.276; TCGA PRAD -0.176; TCGA SARC -0.162; TCGA STAD -0.285; TCGA UCEC -0.14 |
hsa-miR-26a-5p | UBXN7 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BRCA -0.224; TCGA CESC -0.189; TCGA COAD -0.257; TCGA ESCA -0.197; TCGA KIRC -0.22; TCGA LUAD -0.12; TCGA LUSC -0.556; TCGA SARC -0.199; TCGA STAD -0.263 |
hsa-miR-26a-5p | BRWD3 | 10 cancers: BRCA; CESC; COAD; KIRC; LGG; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.258; TCGA CESC -0.239; TCGA COAD -0.237; TCGA KIRC -0.416; TCGA LGG -0.163; TCGA LUAD -0.15; TCGA LUSC -0.324; TCGA SARC -0.128; TCGA STAD -0.204; TCGA UCEC -0.337 |
hsa-miR-26a-5p | IRGQ | 9 cancers: BRCA; HNSC; KIRP; LIHC; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.109; TCGA HNSC -0.067; TCGA KIRP -0.118; TCGA LIHC -0.297; TCGA LUSC -0.203; TCGA PRAD -0.255; TCGA THCA -0.104; TCGA STAD -0.465; TCGA UCEC -0.166 |
hsa-miR-26a-5p | CSNK1G1 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.154; TCGA COAD -0.201; TCGA ESCA -0.298; TCGA KIRC -0.185; TCGA KIRP -0.09; TCGA LUSC -0.287; TCGA PAAD -0.11; TCGA SARC -0.051; TCGA STAD -0.247; TCGA UCEC -0.153 |
hsa-miR-26a-5p | UBE2V2 | 12 cancers: BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.238; TCGA ESCA -0.259; TCGA HNSC -0.312; TCGA LIHC -0.231; TCGA LUAD -0.193; TCGA LUSC -0.417; TCGA OV -0.171; TCGA PAAD -0.117; TCGA PRAD -0.173; TCGA SARC -0.153; TCGA STAD -0.149; TCGA UCEC -0.219 |
hsa-miR-26a-5p | RAB3B | 12 cancers: BRCA; CESC; COAD; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.532; TCGA CESC -0.448; TCGA COAD -0.597; TCGA KIRP -0.683; TCGA LIHC -0.421; TCGA LUAD -0.759; TCGA LUSC -1.769; TCGA OV -0.356; TCGA PRAD -0.59; TCGA SARC -0.298; TCGA STAD -0.354; TCGA UCEC -0.506 |
hsa-miR-26a-5p | VANGL1 | 10 cancers: BRCA; CESC; ESCA; KIRC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.377; TCGA CESC -0.163; TCGA ESCA -0.22; TCGA KIRC -0.175; TCGA LUAD -0.164; TCGA LUSC -0.505; TCGA PAAD -0.545; TCGA SARC -0.092; TCGA STAD -0.304; TCGA UCEC -0.099 |
hsa-miR-26a-5p | NFATC2IP | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.051; TCGA HNSC -0.055; TCGA KIRP -0.244; TCGA LGG -0.091; TCGA LIHC -0.161; TCGA LUSC -0.105; TCGA SARC -0.203; TCGA STAD -0.086; TCGA UCEC -0.089 |
hsa-miR-26a-5p | PDXDC1 | 11 cancers: BRCA; CESC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.329; TCGA CESC -0.148; TCGA KIRC -0.101; TCGA KIRP -0.111; TCGA LGG -0.065; TCGA LUSC -0.153; TCGA PAAD -0.229; TCGA PRAD -0.337; TCGA SARC -0.106; TCGA THCA -0.137; TCGA UCEC -0.228 |
hsa-miR-26a-5p | NPLOC4 | 11 cancers: BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BRCA -0.119; TCGA ESCA -0.134; TCGA HNSC -0.146; TCGA KIRP -0.141; TCGA LIHC -0.281; TCGA LUAD -0.185; TCGA LUSC -0.266; TCGA PAAD -0.108; TCGA PRAD -0.197; TCGA SARC -0.07; TCGA THCA -0.076 |
hsa-miR-26a-5p | GJC1 | 11 cancers: BRCA; CESC; COAD; HNSC; LIHC; LUAD; OV; PAAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.149; TCGA CESC -0.281; TCGA COAD -0.453; TCGA HNSC -0.415; TCGA LIHC -0.195; TCGA LUAD -0.169; TCGA OV -0.312; TCGA PAAD -0.265; TCGA SARC -0.25; TCGA THCA -0.495; TCGA STAD -0.553 |
hsa-miR-26a-5p | ZNF623 | 11 cancers: BRCA; CESC; COAD; ESCA; LGG; LIHC; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.283; TCGA CESC -0.184; TCGA COAD -0.163; TCGA ESCA -0.286; TCGA LGG -0.072; TCGA LIHC -0.178; TCGA LUAD -0.124; TCGA LUSC -0.428; TCGA SARC -0.111; TCGA STAD -0.273; TCGA UCEC -0.13 |
hsa-miR-26a-5p | XPOT | 10 cancers: BRCA; CESC; KIRC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.288; TCGA CESC -0.128; TCGA KIRC -0.143; TCGA LGG -0.082; TCGA LUAD -0.209; TCGA LUSC -0.487; TCGA PRAD -0.273; TCGA THCA -0.137; TCGA STAD -0.22; TCGA UCEC -0.143 |
hsa-miR-26a-5p | ZNF286A | 10 cancers: BRCA; CESC; COAD; KIRP; LGG; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.101; TCGA CESC -0.172; TCGA COAD -0.175; TCGA KIRP -0.121; TCGA LGG -0.158; TCGA LUAD -0.156; TCGA LUSC -0.27; TCGA SARC -0.115; TCGA STAD -0.355; TCGA UCEC -0.1 |
hsa-miR-26a-5p | CENPP | 11 cancers: BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.146; TCGA ESCA -0.46; TCGA HNSC -0.208; TCGA LIHC -0.521; TCGA LUAD -0.201; TCGA LUSC -0.668; TCGA OV -0.268; TCGA PAAD -0.241; TCGA PRAD -0.224; TCGA THCA -0.253; TCGA STAD -0.13 |
hsa-miR-26a-5p | SF3B3 | 9 cancers: BRCA; COAD; KIRC; KIRP; LGG; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BRCA -0.219; TCGA COAD -0.109; TCGA KIRC -0.131; TCGA KIRP -0.145; TCGA LGG -0.071; TCGA LUAD -0.099; TCGA LUSC -0.281; TCGA STAD -0.112; TCGA UCEC -0.119 |
hsa-miR-26a-5p | XPNPEP3 | 9 cancers: BRCA; ESCA; KIRC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.163; TCGA ESCA -0.17; TCGA KIRC -0.121; TCGA LUSC -0.447; TCGA PAAD -0.144; TCGA PRAD -0.18; TCGA SARC -0.053; TCGA STAD -0.225; TCGA UCEC -0.116 |
hsa-miR-26a-5p | POM121 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; UCEC | mirMAP | TCGA BRCA -0.07; TCGA ESCA -0.198; TCGA KIRC -0.2; TCGA KIRP -0.182; TCGA LGG -0.054; TCGA LUAD -0.119; TCGA LUSC -0.28; TCGA PRAD -0.139; TCGA UCEC -0.12 |
hsa-miR-26a-5p | PRPF40A | 10 cancers: BRCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; OV; STAD; UCEC | mirMAP | TCGA BRCA -0.171; TCGA CESC -0.081; TCGA ESCA -0.153; TCGA KIRC -0.093; TCGA LGG -0.084; TCGA LUAD -0.087; TCGA LUSC -0.272; TCGA OV -0.059; TCGA STAD -0.228; TCGA UCEC -0.15 |
hsa-miR-26a-5p | SLC7A11 | 10 cancers: BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.351; TCGA HNSC -0.564; TCGA KIRC -0.371; TCGA LIHC -1.08; TCGA LUAD -0.455; TCGA LUSC -1.605; TCGA PRAD -0.653; TCGA SARC -0.231; TCGA THCA -0.22; TCGA UCEC -0.261 |
hsa-miR-26a-5p | NLK | 9 cancers: BRCA; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.185; TCGA ESCA -0.127; TCGA HNSC -0.087; TCGA KIRP -0.194; TCGA LUAD -0.111; TCGA PRAD -0.11; TCGA THCA -0.074; TCGA STAD -0.095; TCGA UCEC -0.156 |
hsa-miR-26a-5p | LARP1 | 9 cancers: BRCA; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; STAD | miRNATAP | TCGA BRCA -0.174; TCGA ESCA -0.103; TCGA KIRC -0.184; TCGA LIHC -0.215; TCGA LUAD -0.145; TCGA LUSC -0.253; TCGA PRAD -0.176; TCGA SARC -0.125; TCGA STAD -0.217 |
hsa-miR-26a-5p | CCNJ | 9 cancers: BRCA; KIRC; KIRP; LGG; LUAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.188; TCGA KIRC -0.199; TCGA KIRP -0.088; TCGA LGG -0.173; TCGA LUAD -0.118; TCGA PRAD -0.142; TCGA THCA -0.128; TCGA STAD -0.336; TCGA UCEC -0.381 |
hsa-miR-26a-5p | REEP3 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.213; TCGA CESC -0.253; TCGA COAD -0.156; TCGA ESCA -0.238; TCGA HNSC -0.134; TCGA KIRC -0.193; TCGA LUSC -0.174; TCGA PAAD -0.408; TCGA PRAD -0.235; TCGA SARC -0.223; TCGA THCA -0.149; TCGA STAD -0.441; TCGA UCEC -0.226 |
hsa-miR-26a-5p | PHF20L1 | 10 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; OV; SARC; STAD | miRNATAP | TCGA BRCA -0.214; TCGA CESC -0.092; TCGA ESCA -0.342; TCGA LGG -0.091; TCGA LIHC -0.194; TCGA LUAD -0.085; TCGA LUSC -0.257; TCGA OV -0.133; TCGA SARC -0.092; TCGA STAD -0.349 |
hsa-miR-26a-5p | FBXL19 | 14 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.217; TCGA CESC -0.101; TCGA ESCA -0.311; TCGA HNSC -0.252; TCGA KIRP -0.341; TCGA LGG -0.165; TCGA LIHC -0.348; TCGA LUAD -0.414; TCGA LUSC -0.541; TCGA OV -0.094; TCGA PRAD -0.243; TCGA SARC -0.059; TCGA THCA -0.101; TCGA UCEC -0.148 |
hsa-miR-26a-5p | TANC2 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LGG; PAAD; THCA; STAD | miRNATAP | TCGA BRCA -0.391; TCGA COAD -0.382; TCGA ESCA -0.574; TCGA HNSC -0.184; TCGA KIRC -0.386; TCGA LGG -0.081; TCGA PAAD -0.245; TCGA THCA -0.203; TCGA STAD -0.283 |
hsa-miR-26a-5p | TFAP2A | 9 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.275; TCGA ESCA -1.089; TCGA HNSC -0.27; TCGA LGG -0.408; TCGA LUAD -0.383; TCGA LUSC -1.545; TCGA PAAD -0.765; TCGA STAD -0.508; TCGA UCEC -0.98 |
hsa-miR-26a-5p | MLEC | 10 cancers: BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; UCEC | miRNATAP | TCGA BRCA -0.133; TCGA COAD -0.216; TCGA KIRC -0.261; TCGA KIRP -0.134; TCGA LIHC -0.395; TCGA LUAD -0.123; TCGA LUSC -0.102; TCGA PRAD -0.269; TCGA SARC -0.108; TCGA UCEC -0.151 |
hsa-miR-26a-5p | COL11A1 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BRCA -1.535; TCGA CESC -1.207; TCGA COAD -0.929; TCGA ESCA -1.727; TCGA HNSC -0.845; TCGA LUAD -0.978; TCGA LUSC -1.991; TCGA PAAD -1.306; TCGA PRAD -0.535; TCGA STAD -1.594 |
hsa-miR-26a-5p | TMTC3 | 10 cancers: BRCA; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.221; TCGA COAD -0.147; TCGA ESCA -0.53; TCGA KIRC -0.316; TCGA LUAD -0.172; TCGA LUSC -0.677; TCGA OV -0.092; TCGA PAAD -0.209; TCGA STAD -0.37; TCGA UCEC -0.178 |
hsa-miR-26a-5p | SRPK1 | 13 cancers: BRCA; CESC; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.332; TCGA CESC -0.106; TCGA ESCA -0.186; TCGA KIRP -0.085; TCGA LGG -0.113; TCGA LIHC -0.228; TCGA LUAD -0.17; TCGA LUSC -0.478; TCGA PAAD -0.185; TCGA PRAD -0.157; TCGA SARC -0.133; TCGA STAD -0.225; TCGA UCEC -0.269 |
hsa-miR-26a-5p | PDCD10 | 11 cancers: BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.261; TCGA ESCA -0.239; TCGA HNSC -0.165; TCGA KIRP -0.159; TCGA LUAD -0.093; TCGA LUSC -0.47; TCGA PAAD -0.178; TCGA PRAD -0.164; TCGA SARC -0.127; TCGA STAD -0.148; TCGA UCEC -0.131 |
hsa-miR-26a-5p | ITGA5 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.131; TCGA CESC -0.323; TCGA COAD -0.631; TCGA ESCA -0.274; TCGA HNSC -0.545; TCGA LUAD -0.205; TCGA PAAD -0.595; TCGA SARC -0.205; TCGA THCA -0.279; TCGA STAD -0.34 |
hsa-miR-26a-5p | SUZ12 | 9 cancers: BRCA; COAD; ESCA; LGG; LUAD; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.14; TCGA COAD -0.139; TCGA ESCA -0.138; TCGA LGG -0.068; TCGA LUAD -0.146; TCGA LUSC -0.273; TCGA SARC -0.126; TCGA STAD -0.271; TCGA UCEC -0.212 |
hsa-miR-26a-5p | KLHL18 | 9 cancers: BRCA; CESC; COAD; ESCA; LIHC; LUAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.101; TCGA CESC -0.105; TCGA COAD -0.094; TCGA ESCA -0.136; TCGA LIHC -0.109; TCGA LUAD -0.082; TCGA SARC -0.09; TCGA STAD -0.177; TCGA UCEC -0.201 |
hsa-miR-26a-5p | KCMF1 | 11 cancers: BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.137; TCGA ESCA -0.199; TCGA HNSC -0.16; TCGA LIHC -0.144; TCGA LUAD -0.111; TCGA LUSC -0.349; TCGA OV -0.063; TCGA PAAD -0.13; TCGA PRAD -0.172; TCGA STAD -0.072; TCGA UCEC -0.108 |
hsa-miR-26a-5p | CEBPG | 9 cancers: BRCA; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; THCA | miRNATAP | TCGA BRCA -0.114; TCGA ESCA -0.282; TCGA HNSC -0.103; TCGA LUAD -0.107; TCGA LUSC -0.407; TCGA OV -0.123; TCGA PRAD -0.107; TCGA SARC -0.178; TCGA THCA -0.116 |
hsa-miR-26a-5p | FAM49B | 9 cancers: BRCA; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; UCEC | miRNATAP | TCGA BRCA -0.215; TCGA ESCA -0.374; TCGA HNSC -0.204; TCGA KIRC -0.147; TCGA LIHC -0.325; TCGA LUAD -0.119; TCGA LUSC -0.264; TCGA OV -0.211; TCGA UCEC -0.218 |
hsa-miR-26a-5p | COL10A1 | 9 cancers: BRCA; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -1.212; TCGA COAD -0.88; TCGA ESCA -1.005; TCGA HNSC -0.646; TCGA LUSC -0.874; TCGA PAAD -0.758; TCGA PRAD -0.713; TCGA STAD -1.279; TCGA UCEC -0.405 |
hsa-miR-26a-5p | XPR1 | 9 cancers: BRCA; CESC; ESCA; KIRC; LUSC; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.189; TCGA CESC -0.153; TCGA ESCA -0.489; TCGA KIRC -0.12; TCGA LUSC -0.585; TCGA SARC -0.147; TCGA THCA -0.329; TCGA STAD -0.282; TCGA UCEC -0.16 |
hsa-miR-26a-5p | FANCA | 11 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.423; TCGA CESC -0.134; TCGA HNSC -0.233; TCGA KIRC -0.786; TCGA KIRP -0.582; TCGA LIHC -0.32; TCGA LUAD -0.444; TCGA LUSC -0.598; TCGA SARC -0.163; TCGA THCA -0.335; TCGA UCEC -0.404 |
hsa-miR-26a-5p | ANKIB1 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; SARC; STAD | miRNATAP | TCGA BRCA -0.205; TCGA ESCA -0.202; TCGA KIRC -0.232; TCGA KIRP -0.288; TCGA LGG -0.078; TCGA LUAD -0.142; TCGA LUSC -0.271; TCGA PAAD -0.209; TCGA SARC -0.142; TCGA STAD -0.326 |
hsa-miR-26a-5p | CAPZA1 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.168; TCGA ESCA -0.272; TCGA HNSC -0.077; TCGA KIRC -0.255; TCGA KIRP -0.103; TCGA LUSC -0.118; TCGA OV -0.076; TCGA PRAD -0.1; TCGA THCA -0.071; TCGA UCEC -0.156 |
hsa-miR-26a-5p | TMCC1 | 10 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BRCA -0.169; TCGA ESCA -0.315; TCGA HNSC -0.113; TCGA KIRC -0.336; TCGA LGG -0.146; TCGA LIHC -0.264; TCGA LUSC -0.186; TCGA PAAD -0.201; TCGA PRAD -0.185; TCGA STAD -0.323 |
hsa-miR-26a-5p | ZNF697 | 10 cancers: BRCA; CESC; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.182; TCGA CESC -0.296; TCGA HNSC -0.19; TCGA LUAD -0.154; TCGA LUSC -0.203; TCGA PAAD -0.269; TCGA PRAD -0.479; TCGA THCA -0.144; TCGA STAD -0.277; TCGA UCEC -0.137 |
hsa-miR-26a-5p | BAK1 | 9 cancers: BRCA; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.187; TCGA ESCA -0.221; TCGA HNSC -0.352; TCGA LIHC -0.258; TCGA LUSC -0.342; TCGA PAAD -0.181; TCGA PRAD -0.107; TCGA THCA -0.121; TCGA UCEC -0.11 |
hsa-miR-26a-5p | ATP2C1 | 9 cancers: BRCA; COAD; ESCA; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.204; TCGA COAD -0.081; TCGA ESCA -0.287; TCGA KIRP -0.083; TCGA LUSC -0.245; TCGA PAAD -0.141; TCGA PRAD -0.342; TCGA STAD -0.219; TCGA UCEC -0.229 |
hsa-miR-26a-5p | YES1 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.19; TCGA CESC -0.131; TCGA COAD -0.156; TCGA ESCA -0.177; TCGA HNSC -0.078; TCGA LUAD -0.151; TCGA LUSC -0.324; TCGA PAAD -0.202; TCGA PRAD -0.157; TCGA STAD -0.349; TCGA UCEC -0.209 |
hsa-miR-26a-5p | COL5A1 | 9 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD | miRNATAP | TCGA BRCA -0.487; TCGA COAD -0.54; TCGA ESCA -0.582; TCGA HNSC -0.491; TCGA LUAD -0.287; TCGA LUSC -0.464; TCGA PAAD -0.757; TCGA THCA -0.322; TCGA STAD -0.434 |
hsa-miR-26a-5p | STMN1 | 9 cancers: BRCA; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.296; TCGA KIRP -0.187; TCGA LIHC -0.436; TCGA LUAD -0.268; TCGA LUSC -0.396; TCGA OV -0.368; TCGA PRAD -0.166; TCGA THCA -0.121; TCGA UCEC -0.355 |
hsa-miR-26a-5p | GTF3C2 | 13 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNATAP | TCGA BRCA -0.168; TCGA CESC -0.086; TCGA COAD -0.094; TCGA ESCA -0.123; TCGA KIRC -0.101; TCGA KIRP -0.071; TCGA LGG -0.126; TCGA LIHC -0.128; TCGA LUAD -0.169; TCGA LUSC -0.313; TCGA PAAD -0.108; TCGA PRAD -0.132; TCGA UCEC -0.145 |
hsa-miR-26a-5p | VDAC1 | 12 cancers: BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.215; TCGA HNSC -0.074; TCGA KIRC -0.204; TCGA LIHC -0.185; TCGA LUAD -0.117; TCGA LUSC -0.33; TCGA OV -0.094; TCGA PAAD -0.158; TCGA PRAD -0.243; TCGA SARC -0.057; TCGA THCA -0.256; TCGA UCEC -0.217 |
hsa-miR-26a-5p | RANBP9 | 9 cancers: BRCA; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.241; TCGA LUSC -0.102; TCGA OV -0.076; TCGA PAAD -0.171; TCGA PRAD -0.186; TCGA SARC -0.16; TCGA THCA -0.097; TCGA STAD -0.282; TCGA UCEC -0.083 |
hsa-miR-26a-5p | UBE2L3 | 9 cancers: BRCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; UCEC | miRNATAP | TCGA BRCA -0.098; TCGA HNSC -0.162; TCGA LIHC -0.112; TCGA LUAD -0.086; TCGA LUSC -0.21; TCGA OV -0.19; TCGA PAAD -0.141; TCGA PRAD -0.134; TCGA UCEC -0.08 |
hsa-miR-26a-5p | C20orf24 | 10 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA | miRNATAP | TCGA BRCA -0.251; TCGA HNSC -0.184; TCGA KIRP -0.15; TCGA LIHC -0.332; TCGA LUAD -0.217; TCGA LUSC -0.661; TCGA OV -0.191; TCGA PRAD -0.243; TCGA SARC -0.12; TCGA THCA -0.269 |
hsa-miR-26a-5p | E2F2 | 9 cancers: BRCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; UCEC | miRNATAP | TCGA BRCA -0.479; TCGA KIRC -0.509; TCGA KIRP -0.351; TCGA LGG -0.239; TCGA LIHC -0.616; TCGA LUAD -0.502; TCGA LUSC -0.842; TCGA PRAD -0.271; TCGA UCEC -0.624 |
hsa-miR-26a-5p | NDFIP2 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; OV; STAD; UCEC | miRNATAP | TCGA BRCA -0.086; TCGA ESCA -0.291; TCGA HNSC -0.175; TCGA KIRC -0.206; TCGA KIRP -0.126; TCGA LUSC -0.179; TCGA OV -0.097; TCGA STAD -0.171; TCGA UCEC -0.17 |
hsa-miR-26a-5p | MMP14 | 9 cancers: BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | miRNATAP | TCGA BRCA -0.379; TCGA ESCA -0.407; TCGA HNSC -0.236; TCGA KIRP -0.21; TCGA LUAD -0.237; TCGA LUSC -0.514; TCGA PAAD -0.645; TCGA THCA -0.184; TCGA STAD -0.165 |
hsa-miR-26a-5p | CDR2L | 10 cancers: BRCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.196; TCGA HNSC -0.36; TCGA KIRP -0.48; TCGA LUAD -0.237; TCGA LUSC -0.154; TCGA PAAD -0.477; TCGA PRAD -0.455; TCGA SARC -0.08; TCGA THCA -0.455; TCGA UCEC -0.158 |
hsa-miR-26a-5p | SACS | 9 cancers: CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; SARC; STAD | MirTarget; miRNATAP | TCGA CESC -0.274; TCGA COAD -0.245; TCGA ESCA -0.263; TCGA KIRC -0.258; TCGA KIRP -0.385; TCGA LGG -0.079; TCGA LUAD -0.131; TCGA SARC -0.167; TCGA STAD -0.495 |
hsa-miR-26a-5p | POLR3G | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; STAD | MirTarget | TCGA CESC -0.266; TCGA COAD -0.346; TCGA ESCA -0.637; TCGA HNSC -0.306; TCGA KIRC -0.334; TCGA KIRP -0.127; TCGA LIHC -0.369; TCGA LUAD -0.347; TCGA LUSC -0.529; TCGA STAD -0.585 |
hsa-miR-26a-5p | COASY | 9 cancers: ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA ESCA -0.129; TCGA HNSC -0.205; TCGA KIRP -0.243; TCGA LIHC -0.271; TCGA LUAD -0.21; TCGA LUSC -0.385; TCGA PRAD -0.326; TCGA THCA -0.193; TCGA UCEC -0.11 |
hsa-miR-26a-5p | GDAP1 | 9 cancers: ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD | miRNAWalker2 validate; miRTarBase | TCGA ESCA -0.453; TCGA HNSC -0.122; TCGA KIRP -0.126; TCGA LGG -0.151; TCGA LIHC -0.22; TCGA LUAD -0.164; TCGA LUSC -0.525; TCGA PRAD -0.18; TCGA STAD -0.261 |
hsa-miR-26a-5p | STK39 | 10 cancers: KIRC; KIRP; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA KIRC -0.659; TCGA KIRP -0.347; TCGA LIHC -0.423; TCGA LUSC -0.333; TCGA OV -0.193; TCGA PRAD -0.619; TCGA SARC -0.153; TCGA THCA -0.21; TCGA STAD -0.17; TCGA UCEC -0.218 |
Enriched cancer pathways of putative targets